author = {Joseph A. Fraietta and Simon F. Lacey and Elena J. Orlando and Iulian Pruteanu-Malinici and Mercy Gohil and Stefan Lundh and Alina C. Boesteanu and Yan Wang and Roddy S. O'Connor and Wei-Ting Hwang and Edward Pequignot and David E. Ambrose and Changfeng Zhang and Nicholas Wilcox and Felipe Bedoya and Corin Dorfmeier and Fang Chen and Lifeng Tian and Harit Parakandi and Minnal Gupta and Regina M. Young and F. Brad Johnson and Irina Kulikovskaya and Li Liu and Jun Xu and Sadik H. Kassim and Megan M. Davis and Bruce L. Levine and Noelle V. Frey and Donald L. Siegel and Alexander C. Huang and E. John Wherry and Hans Bitter and Jennifer L. Brogdon and David L. Porter and Carl H. June and J. Joseph Melenhorst},
title = {Determinants of response and resistance to {CD}19 chimeric antigen receptor ({CAR}) T cell therapy of chronic lymphocytic leukemia},
journal = {Nature Medicine},
year = {2018},
volume = {24},
number = {5},
pages = {563--571},
month = {apr},
doi = {10.1038/s41591-018-0010-1},
publisher = {Springer Nature},
}
@Article{Dwarshuis2017,
author = {Nate J. Dwarshuis and Kirsten Parratt and Adriana Santiago-Miranda and Krishnendu Roy},
title = {Cells as advanced therapeutics: State-of-the-art, challenges, and opportunities in large scale biomanufacturing of high-quality cells for adoptive immunotherapies},
journal = {Advanced Drug Delivery Reviews},
year = {2017},
volume = {114},
pages = {222--239},
month = {may},
doi = {10.1016/j.addr.2017.06.005},
publisher = {Elsevier {BV}},
}
@Article{Fesnak2016,
author = {Andrew D. Fesnak and Carl H. June and Bruce L. Levine},
title = {Engineered T cells: the promise and challenges of cancer immunotherapy},
journal = {Nature Reviews Cancer},
year = {2016},
volume = {16},
number = {9},
pages = {566--581},
month = {sep},
doi = {10.1038/nrc.2016.97},
publisher = {Springer Nature},
}
@Article{Gattinoni2012,
author = {Gattinoni, Luca and Klebanoff, Christopher A and Restifo, Nicholas P},
abstract = {Stem cells are defined by the ability to self-renew and to generate differentiated progeny, qualities that are maintained by evolutionarily conserved pathways that can lead to cancer when deregulated. There is now evidence that these stem cell-like attributes and signalling pathways are also shared among subsets of mature memory T lymphocytes. We discuss how using stem cell-like T cells can overcome the limitations of current adoptive T cell therapies, including inefficient T cell engraftment, persistence and ability to mediate prolonged immune attack. Conferring stemness to antitumour T cells might unleash the full potential of cellular therapies.},
annote = {has good chart of CD8+ T cell differentiation from naive -{\textgreater} stem memory -{\textgreater} central memory -{\textgreater} effector memory -{\textgreater} primary effector a review on the T cell phenotypes most associated with good clinical outcomes in melanoma patients},
publisher = {Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
shorttitle = {Nat Rev Cancer},
}
@Article{Zheng2012,
author = {Zhili Zheng and Nachimuthu Chinnasamy and Richard A Morgan},
title = {Protein L: a novel reagent for the detection of Chimeric Antigen Receptor ({CAR}) expression by flow cytometry},
journal = {Journal of Translational Medicine},
year = {2012},
volume = {10},
number = {1},
pages = {29},
doi = {10.1186/1479-5876-10-29},
publisher = {Springer Nature},
}
@Article{Rosenberg2015,
author = {S. A. Rosenberg and N. P. Restifo},
title = {Adoptive cell transfer as personalized immunotherapy for human cancer},
journal = {Science},
year = {2015},
volume = {348},
number = {6230},
pages = {62--68},
month = {apr},
doi = {10.1126/science.aaa4967},
publisher = {American Association for the Advancement of Science ({AAAS})},
}
@Article{Rosenberg2011,
author = {S. A. Rosenberg and J. C. Yang and R. M. Sherry and U. S. Kammula and M. S. Hughes and G. Q. Phan and D. E. Citrin and N. P. Restifo and P. F. Robbins and J. R. Wunderlich and K. E. Morton and C. M. Laurencot and S. M. Steinberg and D. E. White and M. E. Dudley},
title = {Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy},
journal = {Clinical Cancer Research},
year = {2011},
volume = {17},
number = {13},
pages = {4550--4557},
month = {apr},
doi = {10.1158/1078-0432.ccr-11-0116},
publisher = {American Association for Cancer Research ({AACR})},
}
@Article{Ghassemi2018,
author = {Saba Ghassemi and Selene Nunez-Cruz and Roddy S. O'Connor and Joseph A. Fraietta and Prachi R. Patel and John Scholler and David M. Barrett and Stefan M. Lundh and Megan M. Davis and Felipe Bedoya and Changfeng Zhang and John Leferovich and Simon F. Lacey and Bruce L. Levine and Stephan A. Grupp and Carl H. June and J. Joseph Melenhorst and Michael C. Milone},
title = {{Reducing Ex} {Vivo Culture} Improves the Antileukemic Activity of Chimeric Antigen Receptor ({CAR}) T Cells},
journal = {Cancer Immunology Research},
year = {2018},
volume = {6},
number = {9},
pages = {1100--1109},
month = {jul},
doi = {10.1158/2326-6066.cir-17-0405},
publisher = {American Association for Cancer Research ({AACR})},
}
@Article{Kalos2011,
author = {Kalos, Michael and Levine, Bruce L and Porter, David L and Katz, Sharyn and Grupp, Stephan a and Bagg, Adam and June, Carl H},
abstract = {Tumor immunotherapy with T lymphocytes, which can recognize and destroy malignant cells, has been limited by the ability to isolate and expand T cells restricted to tumor-associated antigens. Chimeric antigen receptors (CARs) composed of antibody binding domains connected to domains that activate T cells could overcome tolerance by allowing T cells to respond to cell surface antigens; however, to date, lymphocytes engineered to express CARs have demonstrated minimal in vivo expansion and antitumor effects in clinical trials. We report that CAR T cells that target CD19 and contain a costimulatory domain from CD137 and the T cell receptor $\zeta$ chain have potent non-cross-resistant clinical activity after infusion in three of three patients treated with advanced chronic lymphocytic leukemia (CLL). The engineered T cells expanded {\textgreater}1000-fold in vivo, trafficked to bone marrow, and continued to express functional CARs at high levels for at least 6 months. Evidence for on-target toxicity included B cell aplasia as well as decreased numbers of plasma cells and hypogammaglobulinemia. On average, each infused CAR-expressing T cell was calculated to eradicate at least 1000 CLL cells. Furthermore, a CD19-specific immune response was demonstrated in the blood and bone marrow, accompanied by complete remission, in two of three patients. Moreover, a portion of these cells persisted as memory CAR(+) T cells and retained anti-CD19 effector functionality, indicating the potential of this major histocompatibility complex-independent approach for the effective treatment of B cell malignancies.},
annote = {the paper from Levine/June that includes the CD107a cytotox assay},
author = {Bashour, Keenan T and Larson, Ryan P and Graef, Patricia and Stemberger, Christian and Lothar, Germeroth and Odegard, Valerie and Ramsborg, Christopher G},
journal = {Blood},
title = {Functional Characterization of a T Cell Stimulation Reagent for the Production of Therapeutic Chimeric Antigen Receptor T Cells},
year = {2015},
issn = {0006-4971},
number = {23},
pages = {1901--1901},
volume = {126},
abstract = {Adoptive cell therapy using gene-modified T cells has demonstrated promising clinical outcomes in hematologic malignancies. Production of gene-modified T cells involves the selection of patient T cells, activation via stimulation through the endogenous T cell receptor (TCR) complex and a costimulatory domain, followed by introduction of a tumor antigen-specific TCR or chimeric antigen receptor (CAR) through gene modification. Here we characterize a soluble T cell stimulation reagent, known as an ExpamerTM reagent, in the production of therapeutic CAR T cells.The Expamer reagent used in these studies is designed to be a late-stage clinical and commercial manufacturing ancillary material with two important attributes that make it highly attractive from a manufacturing and regulatory standpoint; it is a soluble and dissociable reagent. These attributes increase the ease of both introduction and removal from the manufacturing process, giving products manufactured with this reagent consistent product quality and purity. This reagent activates T cells through the simultaneous engagement of the TCR-CD3 complex and the costimulatory receptor CD28 and is compatible with manufacturing of both current and next-generation therapeutics.Purified healthy donor T cells cultured in the presence of the Expamer reagent rapidly fluxed Ca2+, demonstrating the capacity to induce early TCR signaling. Activation through this reagent additionally promotes upregulation of the cell surface activation marker CD25 and proliferation as measured by CFSE dilution. Following stimulation with this reagent, T cells are readily transduced with a CD19-specific CAR construct. The function of CAR T cells generated with this reagent was measured by effector cytokine production, proliferation, and cytolytic activity in the presence of CD19 expressing and control target cells in vitro. CAR T cells robustly produced IFN-ɣ and IL-2 after activation with a CAR specific antigen. In addition, proliferation in the presence of CD19 expressing target cells was observed as measured by CFSE dilution. Finally, significant cytolytic activity against CD19-expressing target cells was observed.Collectively, these data provide evidence that functional engineered T cells can be manufactured using the Expamer reagent and support implementation into the production of both current and next-generation therapeutic gene-modified T cells.The first two authors contributed equally to this work.Disclosures Bashour: Juno Therapeutics: Employment. Larson: Juno Therapeutics: Employment. Graef: Juno Therapeutics: Employment. Stemberger: Juno Therapeutics: Employment. Lothar: Juno Therapeutics: Employment. Odegard: Juno Therapeutics: Employment. Ramsborg: Juno Therapeutics: Employment.↵* Asterisk with author names denotes non-ASH members.},
author = {Keishi Adachi and Yosuke Kano and Tomohiko Nagai and Namiko Okuyama and Yukimi Sakoda and Koji Tamada},
title = {{IL}-7 and {CCL}19 expression in {CAR}-T cells improves immune cell infiltration and {CAR}-T cell survival in the tumor},
journal = {Nature Biotechnology},
year = {2018},
volume = {36},
number = {4},
pages = {346--351},
month = {mar},
doi = {10.1038/nbt.4086},
publisher = {Springer Nature},
}
@Article{Baldan2015,
author = {V Baldan and R Griffiths and R E Hawkins and D E Gilham},
title = {Efficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma},
journal = {British Journal of Cancer},
year = {2015},
volume = {112},
number = {9},
pages = {1510--1518},
month = {mar},
doi = {10.1038/bjc.2015.96},
publisher = {Springer Nature},
}
@Article{Bank1994,
author = {Ilan Bank and Mazal Book and Randle Ware},
title = {Functional Role of {VLA}-1 ({CD}49A) in Adhesion, Cation-Dependent Spreading, and Activation of Cultured Human T Lymphocytes},
journal = {Cellular Immunology},
year = {1994},
volume = {156},
number = {2},
pages = {424--437},
month = {jul},
doi = {10.1006/cimm.1994.1187},
publisher = {Elsevier {BV}},
}
@Article{Ben-Horin2004,
author = {Shomron Ben-Horin and Ilan Bank},
title = {The role of very late antigen-1 in immune-mediated inflammation},
journal = {Clinical Immunology},
year = {2004},
volume = {113},
number = {2},
pages = {119--129},
month = {nov},
doi = {10.1016/j.clim.2004.06.007},
publisher = {Elsevier {BV}},
}
@Article{Besser2010,
author = {M. J. Besser and R. Shapira-Frommer and A. J. Treves and D. Zippel and O. Itzhaki and L. Hershkovitz and D. Levy and A. Kubi and E. Hovav and N. Chermoshniuk and B. Shalmon and I. Hardan and R. Catane and G. Markel and S. Apter and A. Ben-Nun and I. Kuchuk and A. Shimoni and A. Nagler and J. Schachter},
title = {Clinical Responses in a Phase {II} Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients},
journal = {Clinical Cancer Research},
year = {2010},
volume = {16},
number = {9},
pages = {2646--2655},
month = {apr},
doi = {10.1158/1078-0432.ccr-10-0041},
publisher = {American Association for Cancer Research ({AACR})},
}
@Article{Blanc2018,
author = {Charlotte Blanc and Sophie Hans and Thi Tran and Clemence Granier and Antonin Saldman and Marie Anson and Stephane Oudard and Eric Tartour},
title = {Targeting Resident Memory T Cells for Cancer Immunotherapy},
journal = {Frontiers in Immunology},
year = {2018},
volume = {9},
month = {jul},
doi = {10.3389/fimmu.2018.01722},
publisher = {Frontiers Media {SA}},
}
@Article{Boisvert2007,
author = {Marc Boisvert and Steve Gendron and Nizar Chetoui and Fawzi Aoudjit},
title = {Alpha2beta1 integrin signaling augments T cell receptor-dependent production of interferon-gamma in human T cells},
journal = {Molecular Immunology},
year = {2007},
volume = {44},
number = {15},
pages = {3732--3740},
month = {jul},
doi = {10.1016/j.molimm.2007.04.003},
publisher = {Elsevier {BV}},
}
@Article{Brimnes2012,
author = {Marie Klinge Brimnes and Anne Ortved Gang and Marco Donia and Per thor Straten and Inge Marie Svane and Sine Reker Hadrup},
title = {Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and {CD}3/{CD}28 dynabead-induced T cell expansion},
journal = {Cancer Immunology, Immunotherapy},
year = {2012},
volume = {61},
number = {8},
pages = {1221--1231},
month = {jan},
doi = {10.1007/s00262-011-1199-8},
publisher = {Springer Nature},
}
@Article{Buck2016,
author = {Buck, Michael D. and O'Sullivan, David and {Klein Geltink}, Ramon I. and Curtis, Jonathan D. and Chang, ChihHao and Sanin, David E. and Qiu, Jing and Kretz, Oliver and Braas, Daniel and van der Windt, Gerritje J.W. and Chen, Qiongyu and Huang, Stanley Ching-Cheng and O'Neill, Christina M. and Edelson, Brian T. and Pearce, Edward J. and Sesaki, Hiromi and Huber, Tobias B. and Rambold, Angelika S. and Pearce, Erika L.},
abstract = {Activated effector T (TE) cellsaugment anabolic path- ways of metabolism, such as aerobic glycolysis, while memory T (TM) cells engage catabolic path- ways, like fatty acid oxidation (FAO). However, sig- nals that drive these differences remain unclear. Mitochondria are metabolic organelles that actively transform their ultrastructure. Therefore, we ques- tioned whether mitochondrial dynamics controls T cell metabolism. We show that TE cells have punc- tate mitochondria, while TM cells maintain fused net- works. The fusion protein Opa1 is required for TM, but not TE cells after infection, and enforcing fusion in TE cells imposes TM cell characteristics and enhances antitumor function. Our data suggest that, by altering cristae morphology, fusion in TM cells configures electron transport chain (ETC) complex associations favoring oxidative phosphorylation (OXPHOS) and FAO, while fission in TE cells leads to cristae expan- sion, reducing ETC efficiency and promoting aerobic glycolysis. Thus, mitochondrial remodeling is a signaling mechanism that instructs T cell metabolic programming.},
author = {Cheung, Alexander S. and Zhang, David K. Y. and Koshy, Sandeep T. and Mooney, David J.},
title = {Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary {T} cells},
journal = {Nature Biotechnology},
year = {2018},
volume = {36},
number = {2},
pages = {160--169},
month = {jan},
doi = {10.1038/nbt.4047},
publisher = {Springer Nature},
}
@Article{Cho2015,
author = {Hyun-Woo Cho and Su-Yeon Kim and Dae-Hee Sohn and Min-Ji Lee and Mi-Young Park and Hyun-Jung Sohn and Hyun-Il Cho and Tai-Gyu Kim},
title = {Triple costimulation via {CD}80, 4-1BB, and {CD}83 ligand elicits the long-term growth of V$\upgamma$9V$\updelta$2 T cells in low levels of {IL}-2},
journal = {Journal of Leukocyte Biology},
year = {2015},
volume = {99},
number = {4},
pages = {521--529},
month = {nov},
doi = {10.1189/jlb.1hi0814-409rr},
publisher = {Wiley},
}
@Article{Couzin-Frankel2017,
author = {Jennifer Couzin-Frankel},
title = {Supply of promising T cell therapy is strained},
journal = {Science},
year = {2017},
volume = {356},
number = {6343},
pages = {1112--1113},
month = {jun},
doi = {10.1126/science.356.6343.1112},
publisher = {American Association for the Advancement of Science ({AAAS})},
}
@Article{DSouza2006,
author = {W. N. {D'Souza} and S. M. Hedrick},
title = {Cutting Edge: Latecomer {CD}8 T Cells Are Imprinted with a Unique Differentiation Program},
journal = {The Journal of Immunology},
year = {2006},
volume = {177},
number = {2},
pages = {777--781},
month = {jul},
doi = {10.4049/jimmunol.177.2.777},
publisher = {The American Association of Immunologists},
}
@Article{Delalat2017,
author = {Delalat, Bahman and Harding, Frances and Gundsambuu, Batjargal and De-Juan-Pardo, Elena M. and Wunner, Felix M. and Wille, Marie Luise and Jasieniak, Marek and Malatesta, Kristen A.L. and Griesser, Hans J. and Simula, Antonio and Hutmacher, Dietmar W. and Voelcker, Nicolas H. and Barry, Simon C.},
abstract = {One of the most significant hurdles to the affordable, accessible delivery of cell therapy is the cost and difficulty of expanding cells to clinically relevant numbers. Immunotherapy to prevent autoimmune disease, tolerate organ transplants or target cancer critically relies on the expansion of specialized T cell populations. We have designed 3D-printed cell culture lattices with highly organized micron-scale architectures, functionalized via plasma polymerization to bind monoclonal antibodies that trigger cell proliferation. This 3D technology platform facilitate the expansion of therapeutic human T cell subsets, including regulatory, effector, and cytotoxic T cells while maintaining the correct phenotype. Lentiviral gene delivery to T cells is enhanced in the presence of the lattices. Incorporation of the lattice format into existing cell culture vessels such as the G-Rex system is feasible. This cell expansion platform is user-friendly and expedites cell recovery and scale-up, making it ideal for translating T cell therapies from bench to bedside.},
author = {Marie-Andr{\'{e}}e Forget and Shruti Malu and Hui Liu and Christopher Toth and Sourindra Maiti and Charuta Kale and Cara Haymaker and Chantale Bernatchez and Helen Huls and Ena Wang and Francesco M. Marincola and Patrick Hwu and Laurence J.N. Cooper and Laszlo G. Radvanyi},
title = {Activation and Propagation of Tumor-infiltrating Lymphocytes on Clinical-grade Designer Artificial Antigen-presenting Cells for Adoptive Immunotherapy of Melanoma},
title = {Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T~cells specific for tumor antigen {GD}2},
journal = {Cytotherapy},
year = {2015},
volume = {17},
number = {4},
pages = {487--495},
month = {apr},
doi = {10.1016/j.jcyt.2014.12.002},
publisher = {Elsevier {BV}},
}
@Article{Gattinoni2011,
author = {Luca Gattinoni and Enrico Lugli and Yun Ji and Zoltan Pos and Chrystal M Paulos and M{\'{a}}ire F Quigley and Jorge R Almeida and Emma Gostick and Zhiya Yu and Carmine Carpenito and Ena Wang and Daniel C Douek and David A Price and Carl H June and Francesco M Marincola and Mario Roederer and Nicholas P Restifo},
title = {A human memory T cell subset with stem cell{\textendash}like properties},
journal = {Nature Medicine},
year = {2011},
volume = {17},
number = {10},
pages = {1290--1297},
month = {sep},
doi = {10.1038/nm.2446},
publisher = {Springer Nature},
}
@Article{Gendron2003,
author = {Steve Gendron and Julie Couture and Fawzi Aoudjit},
title = {Integrin $\alpha$2$\beta$1Inhibits Fas-mediated Apoptosis in T Lymphocytes by Protein Phosphatase 2A-dependent Activation of the {MAPK}/{ERK} Pathway},
journal = {Journal of Biological Chemistry},
year = {2003},
volume = {278},
number = {49},
pages = {48633--48643},
month = {sep},
doi = {10.1074/jbc.m305169200},
publisher = {American Society for Biochemistry {\&} Molecular Biology ({ASBMB})},
}
@Article{Gerdemann2011,
author = {Gerdemann, Ulrike and Vera, Juan F and Rooney, Cliona M and Leen, Ann M},
journal = {Journal of visualized experiments : JoVE},
abstract = {Viral infections cause morbidity and mortality in allogeneic hematopoietic stem cell transplant (HSCT) recipients. We and others have successfully generated and infused T-cells specific for Epstein Barr virus (EBV), cytomegalovirus (CMV) and Adenovirus (Adv) using monocytes and EBV-transformed lymphoblastoid cell (EBV-LCL) gene-modified with an adenovirus vector as antigen presenting cells (APCs). As few as 2x10(5)/kg trivirus-specific cytotoxic T lymphocytes (CTL) proliferated by several logs after infusion and appeared to prevent and treat even severe viral disease resistant to other available therapies. The broader implementation of this encouraging approach is limited by high production costs, complexity of manufacture and the prolonged time (4-6 weeks for EBV-LCL generation, and 4-8 weeks for CTL manufacture--total 10-14 weeks) for preparation. To overcome these limitations we have developed a new, GMP-compliant CTL production protocol. First, in place of adenovectors to stimulate T-cells we use dendritic cells (DCs) nucleofected with DNA plasmids encoding LMP2, EBNA1 and BZLF1 (EBV), Hexon and Penton (Adv), and pp65 and IE1 (CMV) as antigen-presenting cells. These APCs reactivate T cells specific for all the stimulating antigens. Second, culture of activated T-cells in the presence of IL-4 (1,000 U/ml) and IL-7 (10 ng/ml) increases and sustains the repertoire and frequency of specific T cells in our lines. Third, we have used a new, gas permeable culture device (G-Rex) that promotes the expansion and survival of large cell numbers after a single stimulation, thus removing the requirement for EBV-LCLs and reducing technician intervention. By implementing these changes we can now produce multispecific CTL targeting EBV, CMV, and Adv at a cost per 10(6) cells that is reduced by {\textgreater}90{\%}, and in just 10 days rather than 10 weeks using an approach that may be extended to additional protective viral antigens. Our FDA-approved approach should be of value for prophylactic and treatment applications for high risk allogeneic HSCT recipients.},
annote = {a protocol that demonstrated the G-Rex used to make virus-specific T cells},
author = {Raquel Gomez-Eerland and Bastiaan Nuijen and Bianca Heemskerk and Nienke van Rooij and Joost H. van den Berg and Jos H. Beijnen and Wolfgang Uckert and Pia Kvistborg and Ton N. Schumacher and John B.A.G. Haanen and Annelies Jorritsma},
title = {Manufacture of Gene-Modified Human T-Cells with a Memory Stem/Central Memory Phenotype},
journal = {Human Gene Therapy Methods},
year = {2014},
volume = {25},
number = {5},
pages = {277--287},
month = {oct},
doi = {10.1089/hgtb.2014.004},
publisher = {Mary Ann Liebert Inc},
}
@Article{Harrison2019,
author = {Richard P. Harrison and Ezequiel Zylberberg and Simon Ellison and Bruce L. Levine},
title = {Chimeric antigen receptor{\textendash}T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goods},
journal = {Cytotherapy},
year = {2019},
month = {feb},
doi = {10.1016/j.jcyt.2019.01.003},
publisher = {Elsevier {BV}},
}
@Article{Heathman2015,
author = {Thomas R. J. Heathman and Veronica A. M. Glyn and Andrew Picken and Qasim A. Rafiq and Karen Coopman and Alvin W. Nienow and Bo Kara and Christopher J. Hewitt},
title = {Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process},
journal = {Biotechnology and Bioengineering},
year = {2015},
volume = {112},
number = {8},
pages = {1696--1707},
month = {apr},
doi = {10.1002/bit.25582},
publisher = {Wiley},
}
@Article{Hickey2017,
author = {John W. Hickey and Fernando P. Vicente and Gregory P. Howard and Hai-Quan Mao and Jonathan P. Schneck},
title = {Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation},
journal = {Nano Letters},
year = {2017},
volume = {17},
number = {11},
pages = {7045--7054},
month = {oct},
doi = {10.1021/acs.nanolett.7b03734},
publisher = {American Chemical Society ({ACS})},
}
@Manual{stargazer,
title = {stargazer: Well-Formatted Regression and Summary Statistics Tables},
author = {Marek Hlavac},
organization = {Central European Labour Studies Institute (CELSI)},
address = {Bratislava, Slovakia},
year = {2018},
note = {R package version 5.2.2},
}
@Article{Hromas1997,
author = {Hromas, R and Gray, P W and Chantry, D and Godiska, R and Krathwohl, M and Fife, K and Bell, G I and Takeda, J and Aronica, S and Gordon, M and Cooper, S and Broxmeyer, H E and Klemsz, M J},
abstract = {Chemokines are a family of related proteins that regulate leukocyte infiltration into inflamed tissue. Some chemokines such as MIP-1 alpha also inhibit hematopoietic progenitor cell proliferation. Recently, three chemokines, MIP-1 alpha, MIP-1 beta, and RANTES, have been found to significantly decrease human immunodeficiency virus production from infected T cells. We report here the cloning and characterization of a novel human chemokine termed Exodus for its chemotactic properties. This novel chemokine is distantly related to other chemokines (28% homology with MIP-1 alpha) and shares several biological activities. Exodus is expressed preferentially in lymphocytes and monocytes, and its expression is markedly upregulated by mediators of inflammation such as tumor necrosis factor or lipopolysaccharide. Purified synthetic Exodus was found to inhibit proliferation of myeloid progenitors in colony formation assays. Exodus also stimulated chemotaxis of peripheral blood mononuclear cells. The sequence homology, expression, and biological activity indicate that Exodus represents a novel divergent beta-chemokine.},
author = {Jin, Jianjian and Sabatino, Marianna and Somerville, Robert and Wilson, John R and Dudley, Mark E and Stroncek, David F and Rosenberg, Steven A},
journal = {Journal of immunotherapy (Hagerstown, Md. : 1997)},
abstract = {Adoptive cell therapy of metastatic melanoma with autologous tumor infiltrating lymphocytes (TIL) is clinically effective, but TIL production can be challenging. Here we describe a simplified method for initial TIL culture and rapid expansion in gas-permeable flasks. TIL were initially cultured from tumor digests and fragments in 40 mL capacity flasks with a 10 cm² gas-permeable silicone bottom, G-Rex10. A TIL rapid expansion protocol (REP) was developed using 500 mL capacity flasks with a 100 cm² gas-permeable silicone bottom, G-Rex100. TIL growth was successfully initiated in G-Rex10 flasks from tumor digests from 13 of 14 patients and from tumor fragments in all 11 tumor samples tested. TIL could then be expanded to 8-10×10⁹ cells in a 2-step REP that began by seeding 5×10⁶ TIL into a G-Rex100 flask, followed by expansion at day 7 into 3 G-Rex100 flasks. To obtain the 30-60×10⁹ cells used for patient treatment, we seeded 6 G-Rex100 flasks with 5×10⁶ cells and expanded into 18 G-Rex100 flasks. Large-scale TIL REP in gas-permeable flasks requires approximately 9-10 L of media, about 3-4 times less than other methods. In conclusion, TIL initiation and REP in gas-permeable G-Rex flasks require fewer total vessels, less media, less incubator space, and less labor than initiation and REP in 24-well plates, tissue culture flasks, and bags. TIL culture in G-Rex flasks will facilitate the production of TIL at the numbers required for patient treatment at most cell processing laboratories.},
annote = {this study developed a simpler TIL growth method using closed system with G-Rex flasks and the young TIL method Advantages of this protocol 1) 4 fold media reduction compared to bag or flask method 2) TILs can be grown from tumor fragments that are not digested or mechanically disrupted, reducing labor 3) only 18 G-Rex flasks needed for 25-60e9 cells (compared to 30-50 flasks or 15-30 bags) 4) less incubator space 5) less labor Disadvantages: 1) not fully closed system 2) no visualization},
title = {Effector {CD}8 T Cell Development: A Balancing Act between Memory Cell Potential and Terminal Differentiation},
journal = {The Journal of Immunology},
year = {2008},
volume = {180},
number = {3},
pages = {1309--1315},
month = {jan},
doi = {10.4049/jimmunol.180.3.1309},
publisher = {The American Association of Immunologists},
}
@Article{kaartinen17,
author = {Tanja Kaartinen and Annu Luostarinen and Pilvi Maliniemi and Joni Keto and Mikko Arvas and Heini Belt and Jonna Koponen and Angelica Loskog and Satu Mustjoki and Kimmo Porkka and Seppo Yl{\"a}-Herttuala and Matti Korhonen},
title = {Low Interleukin-2 Concentration Favors Generation of Early Memory T Cells Over Effector Phenotypes During Chimeric Antigen Receptor T-Cell Expansion},
journal = {Cytotherapy},
year = {2017},
volume = {19},
number = {6},
pages = {689-702},
date_added = {Fri Feb 15 13:22:34 2019},
doi = {10.1016/j.jcyt.2017.03.067},
}
@Article{Lalor2016,
author = {Stephen J. Lalor and Rachel M. McLoughlin},
title = {Memory $\upgamma$$\updelta$ T Cells{\textendash}Newly Appreciated Protagonists in Infection and Immunity},
journal = {Trends in Immunology},
year = {2016},
volume = {37},
number = {10},
pages = {690--702},
month = {oct},
doi = {10.1016/j.it.2016.07.006},
publisher = {Elsevier {BV}},
}
@Article{Lambert2017,
author = {Lambert, Lester H. and Goebrecht, Geraldine K. E. and {De Leo}, Sarah E. and O'Connor, Roddy S and Nunez-Cruz, Selene and Li, Tai-De and Yuan, Jinglun and Milone, Michael C. and Kam, Lance C.},
abstract = {Protein-coated microbeads provide a consistent approach for activating and expanding populations of T cells for immunotherapy but do not fully capture the properties of antigen presenting cells. In this report, we enhance T cell expansion by replacing the conventional, rigid bead with a mechanically soft elastomer. Polydimethylsiloxane (PDMS) was prepared in a microbead format and modified with activating antibodies to CD3 and CD28. A total of three different formulations of PDMS provided an extended proliferative phase in both CD4(+)-only and mixed CD4(+)-CD8(+) T cell preparations. CD8(+) T cells retained cytotoxic function, as measured by a set of biomarkers (perforin production, LAMP2 mobilization, and IFN-$\gamma$ secretion) and an in vivo assay of targeted cell killing. Notably, PDMS beads presented a nanoscale polymer structure and higher rigidity than that associated with conventional bulk material. These data suggest T cells respond to this higher rigidity, indicating an unexpected effect of curing conditions. Together, these studies demonstrate that adopting mechanobiology ideas into the bead platform can provide new tools for T cell based immunotherapy.},
author = {Lamers, Cor H J and van Steenbergen-Langeveld, Sabine and van Brakel, Mandy and {Groot-van Ruijven}, Corrien M. and van Elzakker, Pascal M M L and van Krimpen, Brigitte and Sleijfer, Stefan and Debets, Reno},
abstract = {Therapy with autologous T cells that have been gene-engineered to express chimeric antigen receptors (CAR) or T cell receptors (TCR) provides a feasible and broadly applicable treatment for cancer patients. In a clinical study in advanced renal cell carcinoma (RCC) patients with CAR T cells specific for carbonic anhydrase IX (CAIX), we observed toxicities that (most likely) indicated in vivo function of CAR T cells as well as low T cell persistence and clinical response rates. The latter observations were confirmed by later clinical trials in other solid tumor types and other gene-modified T cells. To improve the efficacy of T cell therapy, we have redefined in vitro conditions to generate T cells with young phenotype, a key correlate with clinical outcome. For their impact on gene-modified T cell phenotype and function, we have tested various anti-CD3/CD28 mAb-based T cell activation and expansion conditions as well as several cytokines prior to and/or after gene transfer using two different receptors: CAIX CAR and MAGE-C2(ALK)/HLA-A2 TCR. In a total set of 16 healthy donors, we observed that T cell activation with soluble anti-CD3/CD28 mAbs in the presence of both IL15 and IL21 prior to TCR gene transfer resulted in enhanced proportions of gene-modified T cells with a preferred in vitro phenotype and better function. T cells generated according to these processing methods demonstrated enhanced binding of pMHC, and an enhanced proportion of CD8+, CD27+, CD62L+, CD45RA+T cells. These new conditions will be translated into a GMP protocol in preparation of a clinical adoptive therapy trial to treat patients with MAGE-C2-positive tumors.},
annote = {contains some info on where to find soluble anti-CD3/CD28 for expansion/activation company for soluble Abs = Cilag or Miltenyi ("functional grade") functional grade = low endotoxin, safe buffers, no azides (eg wont kill cells) sCD3 = soluble CD3 bCD3 + 28= MACSiBEAD coated CD3 and CD28},
abstract = {Anti-CD3 (aCD3) nanoarrays fabricated by self-assembled nanopatterning combined with site-directed protein immobilization techniques represent a novel T cell stimulatory platform that allows tight control over ligand orientation and surface density. Here, we show that activation of primary human CD4+ T cells, defined by CD69 upregulation, IL-2 production and cell proliferation, correlates with aCD3 density on nanoarrays. Immobilization of aCD3 through nanopatterning had two effects: cell activation was significantly higher on these surfaces than on aCD3-coated plastics and allowed unprecedented fine-tuning of T cell response.},
annote = {cool method, but seems like there's an underwhelmingly low amount of data here. what happens to the phenotype of these cells as the ligand density changes? These are problably more important questions to answer for biomanufacturing purposes :)},
keywords = {.article, T cell, act, anti-cd3 monoclonal antibody, arti fi cial antigen, bcml, block copolymer micellar nanolithography, cd4, doptive cell therapy, is a promising medical, nanopattern, of cancer and chronic, presenting interfaces, signaling, strategy for the treatment, t cell activation, t cells, viral},
author = {Randall A. Meyer and Joel C. Sunshine and Karlo Perica and Alyssa K. Kosmides and Kent Aje and Jonathan P. Schneck and Jordan J. Green},
title = {Immunoengineering: Biodegradable Nanoellipsoidal Artificial Antigen Presenting Cells for Antigen Specific T-Cell Activation (Small 13/2015)},
journal = {Small},
year = {2015},
volume = {11},
number = {13},
pages = {1612-1612},
date_added = {Fri Feb 8 22:38:01 2019},
doi = {10.1002/smll.201570077},
}
@Article{Milone2009,
author = {Michael C. Milone and Jonathan D. Fish and Carmine Carpenito and Richard G. Carroll and Gwendolyn K. Binder and David Teachey and Minu Samanta and Mehdi Lakhal and Brian Gloss and Gwenn Danet-Desnoyers and Dario Campana and James L. Riley and Stephan A. Grupp and Carl H. June},
title = {Chimeric Receptors Containing {CD}137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo},
journal = {Molecular Therapy},
year = {2009},
volume = {17},
number = {8},
pages = {1453--1464},
month = {aug},
doi = {10.1038/mt.2009.83},
publisher = {Elsevier {BV}},
}
@Article{Ohtani2008,
author = {Osamu Ohtani and Yuko Ohtani},
title = {Structure and function of rat lymph nodes},
journal = {Archives of Histology and Cytology},
year = {2008},
volume = {71},
number = {2},
pages = {69--76},
doi = {10.1679/aohc.71.69},
publisher = {International Society of Histology {\&} Cytology},
}
@Article{Piscopo2017,
author = {Nicole J. Piscopo and Katherine P. Mueller and Amritava Das and Peiman Hematti and William L. Murphy and Sean P. Palecek and Christian M. Capitini and Krishanu Saha},
title = {Bioengineering Solutions for Manufacturing Challenges in {CAR} T Cells},
journal = {Biotechnology Journal},
year = {2017},
volume = {13},
number = {2},
pages = {1700095},
month = {sep},
doi = {10.1002/biot.201700095},
publisher = {Wiley},
}
@Article{Rao2000,
author = {W. H. Rao and J. M. Hales and R. D. R. Camp},
title = {Potent Costimulation of Effector T Lymphocytes by Human Collagen Type I},
journal = {The Journal of Immunology},
year = {2000},
volume = {165},
number = {9},
pages = {4935--4940},
month = {nov},
doi = {10.4049/jimmunol.165.9.4935},
publisher = {The American Association of Immunologists},
}
@Article{Robbins2011,
author = {Paul F. Robbins and Richard A. Morgan and Steven A. Feldman and James C. Yang and Richard M. Sherry and Mark E. Dudley and John R. Wunderlich and Azam V. Nahvi and Lee J. Helman and Crystal L. Mackall and Udai S. Kammula and Marybeth S. Hughes and Nicholas P. Restifo and Mark Raffeld and Chyi-Chia Richard Lee and Catherine L. Levy and Yong F. Li and Mona El-Gamil and Susan L. Schwarz and Carolyn Laurencot and Steven A. Rosenberg},
title = {Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With {NY}-{ESO}-1},
journal = {Journal of Clinical Oncology},
year = {2011},
volume = {29},
number = {7},
pages = {917--924},
month = {mar},
doi = {10.1200/jco.2010.32.2537},
publisher = {American Society of Clinical Oncology ({ASCO})},
}
@Article{Roddie2019,
author = {Claire Roddie and Maeve O'Reilly and Juliana Dias Alves Pinto and Ketki Vispute and Mark Lowdell},
title = {Manufacturing chimeric antigen receptor T cells: issues and challenges},
journal = {Cytotherapy},
year = {2019},
month = {jan},
doi = {10.1016/j.jcyt.2018.11.009},
publisher = {Elsevier {BV}},
}
@Article{Rosato2019,
author = {Pamela C. Rosato and Sathi Wijeyesinghe and J. Michael Stolley and Christine E. Nelson and Rachel L. Davis and Luke S. Manlove and Christopher A. Pennell and Bruce R. Blazar and Clark C. Chen and Melissa A. Geller and Vaiva Vezys and David Masopust},
title = {Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy},
journal = {Nature Communications},
year = {2019},
volume = {10},
number = {1},
month = {feb},
doi = {10.1038/s41467-019-08534-1},
publisher = {Springer Nature},
}
@Article{Rio2018,
author = {Eduardo P{\'{e}}rez del R{\'{\i}}o and Marc Martinez Miguel and Jaume Veciana and Imma Ratera and Judith Guasch},
title = {Artificial 3D Culture Systems for T Cell Expansion},
journal = {{ACS} Omega},
year = {2018},
volume = {3},
number = {5},
pages = {5273--5280},
month = {may},
doi = {10.1021/acsomega.8b00521},
publisher = {American Chemical Society ({ACS})},
}
@Article{Sart2011,
author = {S{\'{e}}bastien Sart and Abdelmounaim Errachid and Yves-Jacques Schneider and Spiros N Agathos},
title = {Controlled expansion and differentiation of mesenchymal stem cells in a microcarrier based stirred bioreactor},
journal = {{BMC} Proceedings},
year = {2011},
volume = {5},
number = {S8},
month = {nov},
doi = {10.1186/1753-6561-5-s8-p55},
publisher = {Springer Nature},
}
@Article{Schmoldt1975,
author = {Schmoldt, A and Benthe, H F and Haberland, G},
title = {Digitoxin metabolism by rat liver microsomes.},
author = {D Sommermeyer and M Hudecek and P L Kosasih and T Gogishvili and D G Maloney and C J Turtle and S R Riddell},
title = {Chimeric antigen receptor-modified T cells derived from defined {CD}8+ and {CD}4+ subsets confer superior antitumor reactivity in vivo},
journal = {Leukemia},
year = {2015},
volume = {30},
number = {2},
pages = {492--500},
month = {sep},
doi = {10.1038/leu.2015.247},
publisher = {Springer Nature},
}
@Article{Straetemans2018,
author = {Trudy Straetemans and Guido J. J. Kierkels and Ruud Doorn and Koen Jansen and Sabine Heijhuurs and Joao M. dos Santos and Anna D. D. van Muyden and Henri Vie and B{\'{e}}atrice Clemenceau and Reinier Raymakers and Moniek de Witte and Zsolt Sebesty{\'{e}}n and Jürgen Kuball},
title = {{GMP}-Grade Manufacturing of T Cells Engineered to Express a Defined $\upgamma$$\updelta${TCR}},
journal = {Frontiers in Immunology},
year = {2018},
volume = {9},
month = {may},
doi = {10.3389/fimmu.2018.01062},
publisher = {Frontiers Media {SA}},
}
@Article{Tumaini2013,
author = {Tumaini, Barbara and Lee, Daniel W and Lin, Tasha and Castiello, Luciano and Stroncek, David F and Mackall, Crystal and Wayne, Alan and Sabatino, Marianna},
abstract = {BACKGROUND AIMS: Adoptive immunotherapy with the use of chimeric antigen receptor (CAR)-engineered T cells specific for CD19 has shown promising results for the treatment of B-cell lymphomas and leukemia. This therapy involves the transduction of autologous T cells with a viral vector and the subsequent cell expansion. We describe a new, simplified method to produce anti-CD19-CAR T cells.
METHODS: T cells were isolated from peripheral blood mononuclear cell (PBMC) with anti-CD3/anti-CD28 paramagnetic beads. After 2 days, the T cells were added to culture bags pre-treated with RetroNectin and loaded with the retroviral anti-CD19 CAR vector. The cells, beads and vector were incubated for 24 h, and a second transduction was then performed. No spinoculation was used. Cells were then expanded for an additional 9 days.
RESULTS: The method was validated through the use of two PBMC products from a patient with B-cell chronic lymphoblastic leukemia and one PBMC product from a healthy subject. The two PBMC products from the patient with B-cell chronic lymphoblastic leukemia contained 11.4{\%} and 12.9{\%} T cells. The manufacturing process led to final products highly enriched in T cells with a mean CD3+ cell content of 98{\%}, a mean expansion of 10.6-fold and a mean transduction efficiency of 68{\%}. Similar results were obtained from the PBMCs of the first four patients with acute lymphoblastic leukemia treated at our institution.
CONCLUSIONS: We developed a simplified, semi-closed system for the initial selection, activation, transduction and expansion of T cells with the use of anti-CD3/anti-CD28 beads and bags to produce autologous anti-CD19 CAR-transduced T cells to support an ongoing clinical trial.},
annote = {a manufacturing process for CD19 CAR T cells. It does not appear that they used a bioreactor},
author = {Cameron J. Turtle and Laïla-Aïcha Hanafi and Carolina Berger and Michael Hudecek and Barbara Pender and Emily Robinson and Reed Hawkins and Colette Chaney and Sindhu Cherian and Xueyan Chen and Lorinda Soma and Brent Wood and Daniel Li and Shelly Heimfeld and Stanley R. Riddell and David G. Maloney},
title = {Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of {CD}8+ and {CD}4+ {CD}19-specific chimeric antigen receptor{\textendash}modified T cells},
journal = {Science Translational Medicine},
year = {2016},
volume = {8},
number = {355},
pages = {355ra116--355ra116},
month = {sep},
doi = {10.1126/scitranslmed.aaf8621},
publisher = {American Association for the Advancement of Science ({AAAS})},
}
@Article{Walseng2017,
author = {Even Walseng and Hakan Köksal and Ibrahim M. Sektioglu and Anne F{\aa}ne and Gjertrud Skorstad and Gunnar Kvalheim and Gustav Gaudernack and Else Marit Inderberg and S{\'{e}}bastien Wälchli},
title = {A {TCR}-based Chimeric Antigen Receptor},
journal = {Scientific Reports},
year = {2017},
volume = {7},
number = {1},
month = {sep},
doi = {10.1038/s41598-017-11126-y},
publisher = {Springer Nature},
}
@Article{Wang2018,
author = {Dongrui Wang and Brenda Aguilar and Renate Starr and Darya Alizadeh and Alfonso Brito and Aniee Sarkissian and Julie R. Ostberg and Stephen J. Forman and Christine E. Brown},
title = {Glioblastoma-targeted {CD}4+ {CAR} T cells mediate superior antitumor activity},
journal = {{JCI} Insight},
year = {2018},
volume = {3},
number = {10},
month = {may},
doi = {10.1172/jci.insight.99048},
publisher = {American Society for Clinical Investigation},
}
@Article{Wang2016,
author = {Xiuyan Wang and Isabelle Rivi{\`{e}}re},
title = {Clinical manufacturing of {CAR} T cells: foundation of a promising therapy},
journal = {Molecular Therapy - Oncolytics},
year = {2016},
volume = {3},
pages = {16015},
doi = {10.1038/mto.2016.15},
publisher = {Elsevier {BV}},
}
@Article{van_der_Windt_2012,
author = {Gerritje~J.W. van~der~Windt and Bart Everts and Chih-Hao Chang and Jonathan~D. Curtis and Tori~C. Freitas and Eyal Amiel and Edward~J. Pearce and Erika~L. Pearce},
title = {Mitochondrial Respiratory Capacity Is a Critical Regulator of {CD}8+ T Cell Memory Development},
journal = {Immunity},
year = {2012},
volume = {36},
number = {1},
pages = {68--78},
month = {jan},
doi = {10.1016/j.immuni.2011.12.007},
publisher = {Elsevier {BV}},
}
@Article{Xu2014,
author = {Xu, Yang and Zhang, Ming and Ramos, Carlos A and Durett, April and Liu, Enli and Dakhova, Olga and Liu, Hao and Creighton, Chad J and Gee, Adrian P and Heslop, Helen E and Rooney, Cliona M and Savoldo, Barbara and Dotti, Gianpietro},
abstract = {Adoptive transfer of T lymphocytes expressing a CD19-specific chimeric antigen receptor (CAR.CD19) induces complete tumor regression in patients with lymphoid malignancies. Although in vivo persistence of CAR-T cells correlates with clinical responses, it remains unknown whether specific cell subsets within the CAR-T-cell product correlate with their subsequent in vivo expansion and persistence. We analyzed 14 patients with B-cell malignancies infused with autologous CAR.CD19-redirected T cells expanded ex vivo using IL-2, and found that their in vivo expansion only correlated with the frequency within the infused product of a CD8(+)CD45RA(+)CCR7(+) subset, whose phenotype is closest to "T-memory stem cells." Preclinical models showed that increasing the frequency of CD8(+)CD45RA(+)CCR7(+) CAR-T cells in the infused line by culturing the cells with IL-7 and IL-15 produced greater antitumor activity of CAR-T cells mediated by increased resistance to cell death, following repetitive encounters with the antigen, while preserving their migration to secondary lymphoid organs. This trial was registered at www.clinicaltrials.gov as NCT00586391 and NCT00709033.},
author = {Yinmeng Yang and M. Eric Kohler and Christopher D. Chien and Christopher T. Sauter and Elad Jacoby and Chunhua Yan and Ying Hu and Kelsey Wanhainen and Haiying Qin and Terry J. Fry},
title = {{TCR} engagement negatively affects {CD}8 but not {CD}4 {CAR} T cell expansion and leukemic clearance},
journal = {Science Translational Medicine},
year = {2017},
volume = {9},
number = {417},
pages = {eaag1209},
month = {nov},
doi = {10.1126/scitranslmed.aag1209},
publisher = {American Association for the Advancement of Science ({AAAS})},
}
@Article{Zah2016,
author = {Zah, Eugenia and Lin, Meng-Yin and Silva-Benedict, Anne and Jensen, Michael C and Chen, Yvonne Y},
author = {Koichi Araki and Alexandra P. Turner and Virginia Oliva Shaffer and Shivaprakash Gangappa and Susanne A. Keller and Martin F. Bachmann and Christian P. Larsen and Rafi Ahmed},
title = {{mTOR} regulates memory {CD}8 T-cell differentiation},
journal = {Nature},
year = {2009},
volume = {460},
number = {7251},
pages = {108--112},
month = {jun},
doi = {10.1038/nature08155},
publisher = {Springer Nature},
}
@Article{Rao2010,
author = {Rajesh R. Rao and Qingsheng Li and Kunle Odunsi and Protul A. Shrikant},
title = {The {mTOR} Kinase Determines Effector versus Memory {CD8+} T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin},
journal = {Immunity},
year = {2010},
volume = {32},
number = {1},
pages = {67--78},
month = {jan},
doi = {10.1016/j.immuni.2009.10.010},
publisher = {Elsevier {BV}},
}
@Book{Defeo2010,
title = {Juran's Quality Handbook: The Complete Guide to Performance Excellence 6/e},
publisher = {McGraw-Hill Education},
year = {2010},
author = {Joseph A. Defeo and J.M. Juran},
isbn = {0071629734},
}
@Article{Pearce2009,
author = {Erika L. Pearce and Matthew C. Walsh and Pedro J. Cejas and Gretchen M. Harms and Hao Shen and Li-San Wang and Russell G. Jones and Yongwon Choi},
title = {Enhancing {CD}8 T-cell memory by modulating fatty acid metabolism},
journal = {Nature},
year = {2009},
volume = {460},
number = {7251},
pages = {103--107},
month = {jun},
doi = {10.1038/nature08097},
publisher = {Springer Nature},
}
@Article{Bruggner2014,
author = {Robert V. Bruggner and Bernd Bodenmiller and David L. Dill and Robert J. Tibshirani and Garry P. Nolan},
title = {Automated identification of stratifying signatures in cellular subpopulations},
journal = {Proceedings of the National Academy of Sciences},
year = {2014},
volume = {111},
number = {26},
pages = {E2770--E2777},
month = {jun},
doi = {10.1073/pnas.1408792111},
publisher = {Proceedings of the National Academy of Sciences},
}
@Article{Spitzer2016,
author = {Matthew~H. Spitzer and Garry~P. Nolan},
title = {Mass Cytometry: Single Cells, Many Features},
journal = {Cell},
year = {2016},
volume = {165},
number = {4},
pages = {780--791},
month = {may},
doi = {10.1016/j.cell.2016.04.019},
publisher = {Elsevier {BV}},
}
@Article{Jung2011,
author = {Jangwook P. Jung and Jos{\'{e}} V. Moyano and Joel H. Collier},
title = {Multifactorial optimization of endothelial cell growth using modular synthetic extracellular matrices},
journal = {Integrative Biology},
year = {2011},
volume = {3},
number = {3},
pages = {185},
doi = {10.1039/c0ib00112k},
publisher = {Oxford University Press ({OUP})},
}
@Article{Schluns2000,
author = {Kimberly S. Schluns and William C Kieper and Stephen C. Jameson and Leo Lefran{\c{c}}ois},
title = {Interleukin-7 mediates the homeostasis of naïve and memory {CD}8 T cells in vivo},
journal = {Nature Immunology},
year = {2000},
volume = {1},
number = {5},
pages = {426--432},
month = {nov},
doi = {10.1038/80868},
publisher = {Springer Nature},
}
@Article{Cieri2012,
author = {N. Cieri and B. Camisa and F. Cocchiarella and M. Forcato and G. Oliveira and E. Provasi and A. Bondanza and C. Bordignon and J. Peccatori and F. Ciceri and M. T. Lupo-Stanghellini and F. Mavilio and A. Mondino and S. Bicciato and A. Recchia and C. Bonini},
title = {{IL}-7 and {IL}-15 instruct the generation of human memory stem T cells from naive precursors},
journal = {Blood},
year = {2012},
volume = {121},
number = {4},
pages = {573--584},
month = {nov},
doi = {10.1182/blood-2012-05-431718},
publisher = {American Society of Hematology},
}
@Article{Smith2015,
author = {Corey Smith and Grethe {\O}kern and Sweera Rehan and Leone Beagley and Sau K Lee and Tanja Aarvak and Karoline W Schjetne and Rajiv Khanna},
title = {Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno-free {CTS} Immune Cell Serum Replacement},
author = {Niwa Ali and Barry Flutter and Robert Sanchez Rodriguez and Ehsan Sharif-Paghaleh and Linda D. Barber and Giovanna Lombardi and Frank O. Nestle},
journal = {{PLoS} {ONE}},
title = {Xenogeneic Graft-versus-Host-Disease in {NOD}-scid {IL}-2R$\upgamma$null Mice Display a T-Effector Memory Phenotype},
author = {Mark Kotanchek and Guido Smits and Ekaterina Vladislavleva},
booktitle = {Genetic and Evolutionary Computation},
publisher = {Springer {US}},
title = {Exploiting Trustable Models via Pareto {GP} for Targeted Data Collection},
year = {2009},
pages = {1--18},
doi = {10.1007/978-0-387-87623-8_10},
}
@Article{Witkowska2005,
author = {Anna Maria Witkowska},
journal = {Mediators of Inflammation},
title = {On the Role of {sIL}-2R Measurements in Rheumatoid Arthritis and Cancers},
year = {2005},
number = {3},
pages = {121--130},
volume = {2005},
doi = {10.1155/mi.2005.121},
publisher = {Hindawi Limited},
}
@Article{Mehta2018,
author = {Amit K. Mehta and Donald T. Gracias and Michael Croft},
journal = {Cytokine},
title = {{TNF} activity and T cells},
year = {2018},
month = {jan},
pages = {14--18},
volume = {101},
doi = {10.1016/j.cyto.2016.08.003},
publisher = {Elsevier {BV}},
}
@Article{Vudattu2005,
author = {Nalini K. Vudattu and Ernst Holler and Patricia Ewing and Ute Schulz and Silvia Haffner and Verena Burger and Silvia Kirchner and Reinhard Andreesen and Gunther Eissner},
journal = {Immunology},
title = {Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of {CD}4+ and {CD}8+ T cells against human microvascular endothelial cells},
year = {2005},
month = {aug},
number = {4},
pages = {536--543},
volume = {115},
doi = {10.1111/j.1365-2567.2005.02190.x},
publisher = {Wiley},
}
@Article{Wong2011,
author = {F. S. Wong},
journal = {Diabetes},
title = {Stimulating {IL}-13 Receptors on T cells: A New Pathway for Tolerance Induction in Diabetes?~},
year = {2011},
month = {may},
number = {6},
pages = {1657--1659},
volume = {60},
doi = {10.2337/db11-0353},
publisher = {American Diabetes Association},
}
@Article{Junttila2018,
author = {Ilkka S. Junttila},
journal = {Frontiers in Immunology},
title = {Tuning the Cytokine Responses: An Update on Interleukin ({IL})-4 and {IL}-13 Receptor Complexes},
year = {2018},
month = {jun},
volume = {9},
doi = {10.3389/fimmu.2018.00888},
publisher = {Frontiers Media {SA}},
}
@Article{Amatya2017,
author = {Nilesh Amatya and Abhishek V. Garg and Sarah L. Gaffen},
journal = {Trends in Immunology},
title = {{IL}-17 Signaling: The Yin and the Yang},
year = {2017},
month = {may},
number = {5},
pages = {310--322},
volume = {38},
doi = {10.1016/j.it.2017.01.006},
publisher = {Elsevier {BV}},
}
@Article{Becher2016,
author = {Burkhard Becher and Sonia Tugues and Melanie Greter},
journal = {Immunity},
title = {{GM}-{CSF}: From Growth Factor to Central Mediator of Tissue Inflammation},
year = {2016},
month = {nov},
number = {5},
pages = {963--973},
volume = {45},
doi = {10.1016/j.immuni.2016.10.026},
publisher = {Elsevier {BV}},
}
@Article{Hurton2016,
author = {Lenka V. Hurton and Harjeet Singh and Amer M. Najjar and Kirsten C. Switzer and Tiejuan Mi and Sourindra Maiti and Simon Olivares and Brian Rabinovich and Helen Huls and Marie-Andr{\'{e}}e Forget and Vrushali Datar and Partow Kebriaei and Dean A. Lee and Richard E. Champlin and Laurence J. N. Cooper},
journal = {Proceedings of the National Academy of Sciences},
title = {Tethered {IL}-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells},
year = {2016},
month = {nov},
number = {48},
pages = {E7788--E7797},
volume = {113},
doi = {10.1073/pnas.1610544113},
publisher = {Proceedings of the National Academy of Sciences},
}
@Article{RonHarel2016,
author = {Noga Ron-Harel and Daniel Santos and Jonathan~M. Ghergurovich and Peter~T. Sage and Anita Reddy and Scott~B. Lovitch and Noah Dephoure and F.~Kyle Satterstrom and Michal Sheffer and Jessica~B. Spinelli and Steven Gygi and Joshua~D. Rabinowitz and Arlene~H. Sharpe and Marcia~C. Haigis},
journal = {Cell Metabolism},
title = {Mitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation},
year = {2016},
month = {jul},
number = {1},
pages = {104--117},
volume = {24},
doi = {10.1016/j.cmet.2016.06.007},
publisher = {Elsevier {BV}},
}
@Article{Pietzke2020,
author = {Matthias Pietzke and Johannes Meiser and Alexei Vazquez},
journal = {Molecular Metabolism},
title = {Formate metabolism in health and disease},
year = {2020},
month = {mar},
pages = {23--37},
volume = {33},
doi = {10.1016/j.molmet.2019.05.012},
publisher = {Elsevier {BV}},
}
@Article{Vardhana2020,
author = {Santosha A. Vardhana and Madeline A. Hwee and Mirela Berisa and Daniel K. Wells and Kathryn E. Yost and Bryan King and Melody Smith and Pamela S. Herrera and Howard Y. Chang and Ansuman T. Satpathy and Marcel R. M. van den Brink and Justin R. Cross and Craig B. Thompson},
journal = {Nature Immunology},
title = {Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen},
year = {2020},
month = {jul},
number = {9},
pages = {1022--1033},
volume = {21},
doi = {10.1038/s41590-020-0725-2},
publisher = {Springer Science and Business Media {LLC}},
}
@Article{Lunt2011,
author = {Sophia Y. Lunt and Matthew G. Vander Heiden},
journal = {Annual Review of Cell and Developmental Biology},
title = {Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation},
year = {2011},
month = {nov},
number = {1},
pages = {441--464},
volume = {27},
doi = {10.1146/annurev-cellbio-092910-154237},
publisher = {Annual Reviews},
}
@Article{Chang2013,
author = {Chih-Hao Chang and Jonathan~D. Curtis and Leonard~B. Maggi and Brandon Faubert and Alejandro~V. Villarino and David O'Sullivan and Stanley~Ching-Cheng Huang and Gerritje~J.W. van~der~Windt and Julianna Blagih and Jing Qiu and Jason~D. Weber and Edward~J. Pearce and Russell~G. Jones and Erika~L. Pearce},
journal = {Cell},
title = {Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis},
year = {2013},
month = {jun},
number = {6},
pages = {1239--1251},
volume = {153},
doi = {10.1016/j.cell.2013.05.016},
publisher = {Elsevier {BV}},
}
@Article{Cao2014,
author = {Yilin Cao and Jeffrey C. Rathmell and Andrew N. Macintyre},
journal = {{PLoS} {ONE}},
title = {Metabolic Reprogramming towards Aerobic Glycolysis Correlates with Greater Proliferative Ability and Resistance to Metabolic Inhibition in {CD}8 versus {CD}4 T Cells},
year = {2014},
month = {aug},
number = {8},
pages = {e104104},
volume = {9},
doi = {10.1371/journal.pone.0104104},
editor = {Michael Platten},
publisher = {Public Library of Science ({PLoS})},
}
@Article{Almeida2016,
author = {Lu{\'{\i}}s Almeida and Matthias Lochner and Luciana Berod and Tim Sparwasser},
journal = {Seminars in Immunology},
title = {Metabolic pathways in T cell activation and lineage differentiation},
year = {2016},
month = {oct},
number = {5},
pages = {514--524},
volume = {28},
doi = {10.1016/j.smim.2016.10.009},
publisher = {Elsevier {BV}},
}
@Article{Wang_2012,
author = {Ruoning Wang and Douglas R Green},
journal = {Nature Immunology},
title = {Metabolic checkpoints in activated T cells},
year = {2012},
month = {sep},
number = {10},
pages = {907--915},
volume = {13},
doi = {10.1038/ni.2386},
publisher = {Springer Science and Business Media {LLC}},
author = {Michael L Dustin and Antonin R de Fougerolles},
journal = {Current Opinion in Immunology},
title = {Reprograming T cells: the role of extracellular matrix in coordination of T cell activation and migration},
year = {2001},
month = {jun},
number = {3},
pages = {286--290},
volume = {13},
doi = {10.1016/s0952-7915(00)00217-x},
publisher = {Elsevier {BV}},
}
@Article{Ebnet1996,
author = {Klaus Ebnet and Eric P. Kaldjian and Arthur O. Anderson and Stephen Shaw},
journal = {Annual Review of Immunology},
title = {{ORCHESTRATED} {INFORMATION} {TRANSFER} {UNDERLYING} {LEUKOCYTE} {ENDOTHELIAL} {INTERACTIONS}},
year = {1996},
month = {apr},
number = {1},
pages = {155--177},
volume = {14},
doi = {10.1146/annurev.immunol.14.1.155},
publisher = {Annual Reviews},
}
@Article{Gunzer2000,
author = {Matthias Gunzer and Angelika Schäfer and Stefan Borgmann and Stephan Grabbe and Kurt S. Zänker and Eva-Bettina Bröcker and Eckhart Kämpgen and Peter Friedl},
journal = {Immunity},
title = {Antigen Presentation in Extracellular Matrix},
year = {2000},
month = {sep},
number = {3},
pages = {323--332},
volume = {13},
doi = {10.1016/s1074-7613(00)00032-7},
publisher = {Elsevier {BV}},
}
@Article{Aoudjit2000,
author = {Aoudjit, F. and Vuori, K.},
journal = {Blood},
title = {Engagement of the alpha2beta1 integrin inhibits Fas ligand expression and activation-induced cell death in T cells in a focal adhesion kinase-dependent manner.},
year = {2000},
issn = {0006-4971},
month = mar,
pages = {2044--2051},
volume = {95},
abstract = {T-cell receptor (TCR)-mediated apoptosis, also known as activation-induced cell death (AICD), plays an important role in the control of immune response and in the development of T-cell repertoire. Mechanistically, AICD has been largely attributed to the interaction of Fas ligand (Fas-L) with its cell surface receptor Fas in activated T cells. Signal transduction mediated by the integrin family of cell adhesion receptors has been previously shown to modulate apoptosis in a number of different cell types; in T cells, integrin signaling is known to be important in cellular response to antigenic challenge by providing a co-stimulatory signal for TCR. In this study we demonstrate that signaling via the collagen receptor alpha2beta1 integrin specifically inhibits AICD by inhibiting Fas-L expression in activated Jurkat T cells. Engagement of the alpha2beta1 integrin with monoclonal antibodies or with type I collagen, a cognate ligand for alpha2beta1, reduced anti-CD3 and PMA/ionomycin-induced cell death by 30% and 40%, respectively, and the expression of Fas-L mRNA by 50%. Further studies indicated that the alpha2beta1-mediated inhibition of AICD and Fas-L expression required the focal adhesion kinase FAK, a known component in the integrin signaling pathways. These results suggest a role for the alpha2beta1 integrin in the control of homeostasis of immune response and T-cell development. (Blood. 2000;95:2044-2051)},
author = {Mingjun Wang and Bingnan Yin and Helen Y Wang and Rong-Fu Wang},
journal = {Immunotherapy},
title = {Current advances in T-cell-based cancer immunotherapy},
year = {2014},
month = {dec},
number = {12},
pages = {1265--1278},
volume = {6},
doi = {10.2217/imt.14.86},
publisher = {Future Medicine Ltd},
}
@Article{Foppen2015,
author = {M.H. Geukes Foppen and M. Donia and I.M. Svane and J.B.A.G. Haanen},
journal = {Molecular Oncology},
title = {Tumor-infiltrating lymphocytes for the treatment of metastatic cancer},
year = {2015},
month = {oct},
number = {10},
pages = {1918--1935},
volume = {9},
doi = {10.1016/j.molonc.2015.10.018},
publisher = {Wiley},
}
@Article{Solinas2017,
author = {Cinzia Solinas and Grazia Pusole and Laura Demurtas and Marco Puzzoni and Roberta Mascia and Gilberto Morgan and Riccardo Giampieri and Mario Scartozzi},
journal = {Critical Reviews in Oncology/Hematology},
title = {Tumor infiltrating lymphocytes in gastrointestinal tumors: Controversies and future clinical implications},
year = {2017},
month = {feb},
pages = {106--116},
volume = {110},
doi = {10.1016/j.critrevonc.2016.11.016},
publisher = {Elsevier {BV}},
}
@Article{June2007,
author = {Carl H. June},
journal = {Journal of Clinical Investigation},
title = {Adoptive T cell therapy for cancer in the clinic},
year = {2007},
month = {jun},
number = {6},
pages = {1466--1476},
volume = {117},
doi = {10.1172/jci32446},
publisher = {American Society for Clinical Investigation},
}
@Article{Santoiemma2015,
author = {Phillip P Santoiemma and Daniel J Powell},
journal = {Cancer Biology {\&} Therapy},
title = {Tumor infiltrating lymphocytes in ovarian cancer},
year = {2015},
month = {apr},
number = {6},
pages = {807--820},
volume = {16},
doi = {10.1080/15384047.2015.1040960},
publisher = {Informa {UK} Limited},
}
@Article{Clark1989,
author = {W. H. Clark and D. E. Elder and D. Guerry and L. E. Braitman and B. J. Trock and D. Schultz and M. Synnestvedt and A. C. Halpern},
journal = {{JNCI} Journal of the National Cancer Institute},
title = {Model Predicting Survival in Stage I Melanoma Based on Tumor Progression},
year = {1989},
month = {dec},
number = {24},
pages = {1893--1904},
volume = {81},
doi = {10.1093/jnci/81.24.1893},
publisher = {Oxford University Press ({OUP})},
}
@Article{Nishimura1999,
author = {Nishimura, M. I. and Avichezer, D. and Custer, M. C. and Lee, C. S. and Chen, C. and Parkhurst, M. R. and Diamond, R. A. and Robbins, P. F. and Schwartzentruber, D. J. and Rosenberg, S. A.},
journal = {Cancer research},
title = {MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte.},
year = {1999},
issn = {0008-5472},
month = dec,
pages = {6230--6238},
volume = {59},
abstract = {It is generally considered that MHC class I-restricted antigens are recognized by CD8+ T cells, whereas MHC class II-restricted antigens are recognized by CD4+ T cells. In the present study, we report an MHC class I-restricted CD4+ T cell isolated from the tumor infiltrating lymphocytes (TILs) of a patient with metastatic melanoma. TIL 1383 I recognized HLA-A2+ melanoma cell lines but not autologous transformed B cells or fibroblasts. The antigen recognized by TIL 1383 I was tyrosinase, and the epitope was the 368-376 peptide. Antibody blocking assays confirmed that TIL 1383 I was MHC class I restricted, and the CD4 and CD8 coreceptors did not contribute significantly to antigen recognition. TIL 1383 I was weakly cytolytic and secreted cytokines in a pattern consistent with it being a Th1 cell. The avidity of TIL 1383 I for peptide pulsed targets is 10-100-fold lower than most melanoma-reactive CD8+ T cell clones. These CD4+ T cells may represent a relatively rare population of T cells that express a T-cell receptor capable of cross-reacting with an MHC class I/peptide complex with sufficient affinity to allow triggering in the absence of the CD4 coreceptor.},
author = {Adriana Cordova and Francesca Toia and Carmela La Mendola and Valentina Orlando and Serena Meraviglia and Gaetana Rinaldi and Matilde Todaro and Giuseppe Cicero and Leonardo Zichichi and Paolo Li Donni and Nadia Caccamo and Giorgio Stassi and Francesco Dieli and Francesco Moschella},
journal = {{PLoS} {ONE}},
title = {Characterization of Human $\upgamma$$\updelta$ T Lymphocytes Infiltrating Primary Malignant Melanomas},
year = {2012},
month = {nov},
number = {11},
pages = {e49878},
volume = {7},
doi = {10.1371/journal.pone.0049878},
editor = {Andrzej T. Slominski},
publisher = {Public Library of Science ({PLoS})},
}
@Article{Morgan2006,
author = {R. A. Morgan and M. E. Dudley and J. R. Wunderlich and M. S. Hughes and J. C. Yang and R. M. Sherry and R. E. Royal and S. L. Topalian and U. S. Kammula and N. P. Restifo and Z. Zheng and A. Nahvi and C. R. de Vries and L. J. Rogers-Freezer and S. A. Mavroukakis and S. A. Rosenberg},
journal = {Science},
title = {Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes},
year = {2006},
month = {oct},
number = {5796},
pages = {126--129},
volume = {314},
doi = {10.1126/science.1129003},
publisher = {American Association for the Advancement of Science ({AAAS})},
}
@Article{Ikeda2016,
author = {Hiroaki Ikeda},
journal = {International Immunology},
title = {T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered {TCR}-T cells: Table 1.},
year = {2016},
month = {apr},
number = {7},
pages = {349--353},
volume = {28},
doi = {10.1093/intimm/dxw022},
publisher = {Oxford University Press ({OUP})},
}
@Article{Gross1989,
author = {G. Gross and T. Waks and Z. Eshhar},
journal = {Proceedings of the National Academy of Sciences},
title = {Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.},
year = {1989},
month = {dec},
number = {24},
pages = {10024--10028},
volume = {86},
doi = {10.1073/pnas.86.24.10024},
publisher = {Proceedings of the National Academy of Sciences},
}
@Article{Brentjens2011,
author = {Renier J. Brentjens and Isabelle Rivi{\`{e}}re and Jae H. Park and Marco L. Davila and Xiuyan Wang and Jolanta Stefanski and Clare Taylor and Raymond Yeh and Shirley Bartido and Oriana Borquez-Ojeda and Malgorzata Olszewska and Yvette Bernal and Hollie Pegram and Mark Przybylowski and Daniel Hollyman and Yelena Usachenko and Domenick Pirraglia and James Hosey and Elmer Santos and Elizabeth Halton and Peter Maslak and David Scheinberg and Joseph Jurcic and Mark Heaney and Glenn Heller and Mark Frattini and Michel Sadelain},
journal = {Blood},
title = {Safety and persistence of adoptively transferred autologous {CD}19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias},
year = {2011},
month = {nov},
number = {18},
pages = {4817--4828},
volume = {118},
doi = {10.1182/blood-2011-04-348540},
publisher = {American Society of Hematology},
}
@Article{Kochenderfer2010,
author = {James N. Kochenderfer and Wyndham H. Wilson and John E. Janik and Mark E. Dudley and Maryalice Stetler-Stevenson and Steven A. Feldman and Irina Maric and Mark Raffeld and Debbie-Ann N. Nathan and Brock J. Lanier and Richard A. Morgan and Steven A. Rosenberg},
journal = {Blood},
title = {Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize {CD}19},
year = {2010},
month = {nov},
number = {20},
pages = {4099--4102},
volume = {116},
doi = {10.1182/blood-2010-04-281931},
publisher = {American Society of Hematology},
}
@Article{Maude2014,
author = {Shannon L. Maude and Noelle Frey and Pamela A. Shaw and Richard Aplenc and David M. Barrett and Nancy J. Bunin and Anne Chew and Vanessa E. Gonzalez and Zhaohui Zheng and Simon F. Lacey and Yolanda D. Mahnke and Jan J. Melenhorst and Susan R. Rheingold and Angela Shen and David T. Teachey and Bruce L. Levine and Carl H. June and David L. Porter and Stephan A. Grupp},
journal = {New England Journal of Medicine},
title = {Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia},
year = {2014},
month = {oct},
number = {16},
pages = {1507--1517},
volume = {371},
doi = {10.1056/nejmoa1407222},
publisher = {Massachusetts Medical Society},
}
@Article{Till2012,
author = {Brian G. Till and Michael C. Jensen and Jinjuan Wang and Xiaojun Qian and Ajay K. Gopal and David G. Maloney and Catherine G. Lindgren and Yukang Lin and John M. Pagel and Lihua E. Budde and Andrew Raubitschek and Stephen J. Forman and Philip D. Greenberg and Stanley R. Riddell and Oliver W. Press},
journal = {Blood},
title = {{CD}20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both {CD}28 and 4-1BB domains: pilot clinical trial results},
year = {2012},
month = {apr},
number = {17},
pages = {3940--3950},
volume = {119},
doi = {10.1182/blood-2011-10-387969},
publisher = {American Society of Hematology},
}
@Article{Till2008,
author = {Brian G. Till and Michael C. Jensen and Jinjuan Wang and Eric Y. Chen and Brent L. Wood and Harvey A. Greisman and Xiaojun Qian and Scott E. James and Andrew Raubitschek and Stephen J. Forman and Ajay K. Gopal and John M. Pagel and Catherine G. Lindgren and Philip D. Greenberg and Stanley R. Riddell and Oliver W. Press},
journal = {Blood},
title = {Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous {CD}20-specific T cells},
year = {2008},
month = {sep},
number = {6},
pages = {2261--2271},
volume = {112},
doi = {10.1182/blood-2007-12-128843},
publisher = {American Society of Hematology},
}
@Article{Guo2016,
author = {Yelei Guo and Yao Wang and Weidong Han},
journal = {Journal of Immunology Research},
title = {Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects},
author = {Daniel Hollyman and Jolanta Stefanski and Mark Przybylowski and Shirley Bartido and Oriana Borquez-Ojeda and Clare Taylor and Raymond Yeh and Vanessa Capacio and Malgorzata Olszewska and James Hosey and Michel Sadelain and Renier J. Brentjens and Isabelle Rivi{\`{e}}re},
journal = {Journal of Immunotherapy},
title = {Manufacturing Validation of Biologically Functional T Cells Targeted to {CD}19 Antigen for Autologous Adoptive Cell Therapy},
author = {R. J. Brentjens and M. L. Davila and I. Riviere and J. Park and X. Wang and L. G. Cowell and S. Bartido and J. Stefanski and C. Taylor and M. Olszewska and O. Borquez-Ojeda and J. Qu and T. Wasielewska and Q. He and Y. Bernal and I. V. Rijo and C. Hedvat and R. Kobos and K. Curran and P. Steinherz and J. Jurcic and T. Rosenblat and P. Maslak and M. Frattini and M. Sadelain},
journal = {Science Translational Medicine},
title = {{CD}19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia},
year = {2013},
month = {mar},
number = {177},
pages = {177ra38--177ra38},
volume = {5},
doi = {10.1126/scitranslmed.3005930},
publisher = {American Association for the Advancement of Science ({AAAS})},
}
@Article{Zhu2018,
author = {Fenlu Zhu and Nirav Shah and Huiqing Xu and Dina Schneider and Rimas Orentas and Boro Dropulic and Parameswaran Hari and Carolyn A. Keever-Taylor},
journal = {Cytotherapy},
title = {Closed-system manufacturing of {CD}19 and dual-targeted {CD}20/19 chimeric antigen receptor T cells using the {CliniMACS} Prodigy device at an academic medical center},
year = {2018},
month = {mar},
number = {3},
pages = {394--406},
volume = {20},
doi = {10.1016/j.jcyt.2017.09.005},
publisher = {Elsevier {BV}},
}
@Article{Kaiser2015,
author = {A D Kaiser and M Assenmacher and B Schröder and M Meyer and R Orentas and U Bethke and B Dropulic},
journal = {Cancer Gene Therapy},
title = {Towards a commercial process for the manufacture of genetically modified T cells for therapy},
year = {2015},
month = {jan},
number = {2},
pages = {72--78},
volume = {22},
doi = {10.1038/cgt.2014.78},
publisher = {Springer Science and Business Media {LLC}},
}
@Article{Bunos2015,
author = {M. Bunos and C. Hümmer and E. Wingenfeld and N. Sorg and V. Pfirrmann and P. Bader and E. Seifried and H. Bönig},
journal = {Vox Sanguinis},
title = {Automated isolation of primary antigen-specific T cells from donor lymphocyte concentrates: results of a feasibility exercise},
year = {2015},
month = {may},
number = {4},
pages = {387--393},
volume = {109},
doi = {10.1111/vox.12291},
publisher = {Wiley},
}
@Article{Somerville2012,
author = {Robert P.T. Somerville and Mark E. Dudley},
author = {Spencer W. Stonier and Kimberly S. Schluns},
journal = {Immunology Letters},
title = {Trans-presentation: A novel mechanism regulating {IL}-15 delivery and responses},
year = {2010},
month = {jan},
number = {2},
pages = {85--92},
volume = {127},
doi = {10.1016/j.imlet.2009.09.009},
publisher = {Elsevier {BV}},
}
@Article{Osinalde2014,
author = {Nerea Osinalde and Virginia Sanchez-Quiles and Vyacheslav Akimov and Barbara Guerra and Blagoy Blagoev and Irina Kratchmarova},
journal = {{PROTEOMICS}},
title = {Simultaneous dissection and comparison of {IL}-2 and {IL}-15 signaling pathways by global quantitative phosphoproteomics},
year = {2014},
month = {sep},
number = {2-3},
pages = {520--531},
volume = {15},
doi = {10.1002/pmic.201400194},
publisher = {Wiley},
}
@Article{Kennedy2000,
author = {Mary K. Kennedy and Moira Glaccum and Sandra N. Brown and Eric A. Butz and Joanne L. Viney and Monica Embers and Naoto Matsuki and Keith Charrier and Lisa Sedger and Cynthia R. Willis and Kenneth Brasel and Philip J. Morrissey and Kim Stocking and JoAnn C. L. Schuh and Sebastian Joyce and Jacques J. Peschon},
journal = {Journal of Experimental Medicine},
title = {Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15{\textendash}Deficient Mice},
year = {2000},
month = {feb},
number = {5},
pages = {771--780},
volume = {191},
doi = {10.1084/jem.191.5.771},
publisher = {Rockefeller University Press},
}
@Article{Lodolce1998,
author = {James P Lodolce and David L Boone and Sophia Chai and Rachel E Swain and Themistocles Dassopoulos and Shanthi Trettin and Averil Ma},
journal = {Immunity},
title = {{IL}-15 Receptor Maintains Lymphoid Homeostasis by Supporting Lymphocyte Homing and Proliferation},
year = {1998},
month = {nov},
number = {5},
pages = {669--676},
volume = {9},
doi = {10.1016/s1074-7613(00)80664-0},
publisher = {Elsevier {BV}},
}
@Article{MirandaCarus2005,
author = {Mar{\'{\i}}a-Eugenia Miranda-Car{\'{u}}s and Marta Benito-Miguel and Miguel A. Llamas and Alejandro Balsa and Emilio Mart{\'{\i}}n-Mola},
journal = {The Journal of Immunology},
title = {Human T Cells Constitutively Express {IL}-15 That Promotes Ex Vivo T Cell Homeostatic Proliferation through Autocrine/Juxtacrine Loops},
year = {2005},
month = {sep},
number = {6},
pages = {3656--3662},
volume = {175},
doi = {10.4049/jimmunol.175.6.3656},
publisher = {The American Association of Immunologists},
}
@Article{Giri1994,
author = {J.G. Giri and M. Ahdieh and J. Eisenman and K. Shanebeck and K. Grabstein and S. Kumaki and A. Namen and L.S. Park and D. Cosman and D. Anderson},
journal = {The {EMBO} Journal},
title = {Utilization of the beta and gamma chains of the {IL}-2 receptor by the novel cytokine {IL}-15.},
year = {1994},
month = {jun},
number = {12},
pages = {2822--2830},
volume = {13},
doi = {10.1002/j.1460-2075.1994.tb06576.x},
publisher = {Wiley},
}
@Article{Giri1995,
author = {J. G. Giri and S. Kumaki and M. Ahdieh and D. J. Friend and A. Loomis and K. Shanebeck and R. DuBose and D. Cosman and L. S. Park and D. M. Anderson},
journal = {The {EMBO} Journal},
title = {Identification and cloning of a novel {IL}-15 binding protein that is structurally related to the alpha chain of the {IL}-2 receptor.},
year = {1995},
month = {aug},
number = {15},
pages = {3654--3663},
volume = {14},
doi = {10.1002/j.1460-2075.1995.tb00035.x},
publisher = {Wiley},
}
@Article{Schluns2004,
author = {Kimberly S. Schluns and Kimberly D. Klonowski and Leo Lefrancois},
journal = {Blood},
title = {Transregulation of memory {CD}8 T-cell proliferation by {IL}-15R$\upalpha$+ bone marrow{\textendash}derived cells},
year = {2004},
month = {feb},
number = {3},
pages = {988--994},
volume = {103},
doi = {10.1182/blood-2003-08-2814},
publisher = {American Society of Hematology},
}
@Article{Burkett2003,
author = {P. R. Burkett and R. Koka and M. Chien and S. Chai and F. Chan and A. Ma and D. L. Boone},
journal = {Proceedings of the National Academy of Sciences},
title = {{IL}-15R~ expression on {CD}8+ T cells is dispensable for T cell memory},
year = {2003},
month = {apr},
number = {8},
pages = {4724--4729},
volume = {100},
doi = {10.1073/pnas.0737048100},
publisher = {Proceedings of the National Academy of Sciences},
}
@Article{Olsen2007,
author = {Shaun K. Olsen and Naruhisa Ota and Seiichiro Kishishita and Mutsuko Kukimoto-Niino and Kazutaka Murayama and Hidemi Uchiyama and Mitsutoshi Toyama and Takaho Terada and Mikako Shirouzu and Osami Kanagawa and Shigeyuki Yokoyama},
journal = {Journal of Biological Chemistry},
title = {Crystal Structure of the Interleukin-15$\cdotp$Interleukin-15 Receptor $\upalpha$ Complex},
year = {2007},
month = {dec},
number = {51},
pages = {37191--37204},
volume = {282},
doi = {10.1074/jbc.m706150200},
publisher = {Elsevier {BV}},
}
@Article{Budagian2004,
author = {Vadim Budagian and Elena Bulanova and Zane Orinska and Andreas Ludwig and Stefan Rose-John and Paul Saftig and Ernest C. Borden and Silvia Bulfone-Paus},
journal = {Journal of Biological Chemistry},
title = {Natural Soluble Interleukin-15R$\upalpha$ Is Generated by Cleavage That Involves the Tumor Necrosis Factor-$\upalpha$-converting Enzyme ({TACE}/{ADAM}17)},
author = {Jie Liu and Guangyu Zhou and Li Zhang and Qi Zhao},
journal = {Frontiers in Immunology},
title = {Building Potent Chimeric Antigen Receptor T Cells With {CRISPR} Genome Editing},
year = {2019},
month = {mar},
volume = {10},
doi = {10.3389/fimmu.2019.00456},
publisher = {Frontiers Media {SA}},
}
@Article{Wiebking2020,
author = {Volker Wiebking and Ciaran M. Lee and Nathalie Mostrel and Premanjali Lahiri and Rasmus Bak and Gang Bao and Maria Grazia Roncarolo and Alice Bertaina and Matthew H. Porteus},
journal = {Haematologica},
title = {Genome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing $\upalpha$$\upbeta$ T cell-depleted haploidentical hematopoietic stem cell transplantation},
year = {2020},
month = {apr},
number = {3},
pages = {847--858},
volume = {106},
doi = {10.3324/haematol.2019.233882},
publisher = {Ferrata Storti Foundation (Haematologica)},
}
@Article{Provasi2012,
author = {Elena Provasi and Pietro Genovese and Angelo Lombardo and Zulma Magnani and Pei-Qi Liu and Andreas Reik and Victoria Chu and David E Paschon and Lei Zhang and Jurgen Kuball and Barbara Camisa and Attilio Bondanza and Giulia Casorati and Maurilio Ponzoni and Fabio Ciceri and Claudio Bordignon and Philip D Greenberg and Michael C Holmes and Philip D Gregory and Luigi Naldini and Chiara Bonini},
journal = {Nature Medicine},
title = {Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer},
year = {2012},
month = {apr},
number = {5},
pages = {807--815},
volume = {18},
doi = {10.1038/nm.2700},
publisher = {Springer Science and Business Media {LLC}},
}
@Article{Berdien2014,
author = {B Berdien and U Mock and D Atanackovic and B Fehse},
journal = {Gene Therapy},
title = {{TALEN}-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer},
year = {2014},
month = {mar},
number = {6},
pages = {539--548},
volume = {21},
doi = {10.1038/gt.2014.26},
publisher = {Springer Science and Business Media {LLC}},
}
@Article{Themeli2015,
author = {Maria Themeli and Isabelle Rivi{\`{e}}re and Michel Sadelain},
journal = {Cell Stem Cell},
title = {New Cell Sources for T Cell Engineering and Adoptive Immunotherapy},
year = {2015},
month = {apr},
number = {4},
pages = {357--366},
volume = {16},
doi = {10.1016/j.stem.2015.03.011},
publisher = {Elsevier {BV}},
}
@Article{Decker2012,
author = {Thomas Decker and Gerhard Fischer and Wolfgang Bücke and Philipp Bücke and Frank Stotz and Andreas Grüneberger and Martina Gropp-Meier and Günther Wiedemann and Christine Pfeiffer and Christian Peschel and Katharina Götze},
journal = {Journal of Cancer Research and Clinical Oncology},
title = {Increased number of regulatory T cells (T-regs) in the peripheral blood of patients with Her-2/neu-positive early breast cancer},
year = {2012},
month = {jul},
number = {11},
pages = {1945--1950},
volume = {138},
doi = {10.1007/s00432-012-1258-3},
publisher = {Springer Science and Business Media {LLC}},
}
@Article{Goldstein2012,
author = {Matthew J. Goldstein and Holbrook E. Kohrt and Roch Houot and Bindu Varghese and Jack T. Lin and Erica Swanson and Ronald Levy},
journal = {Cancer Research},
title = {Adoptive Cell Therapy for Lymphoma with {CD}4 T Cells Depleted of {CD}137-Expressing Regulatory T Cells},
year = {2012},
month = {jan},
number = {5},
pages = {1239--1247},
volume = {72},
doi = {10.1158/0008-5472.can-11-3375},
publisher = {American Association for Cancer Research ({AACR})},
}
@Article{Drela2004,
author = {Nadzieja Drela and Ahmad Jalili and Rafal Kaminski and Katarzyna Kozar and Marek Jak<61>bisiak and Witold Lasek and Grzegorz Basak and Tomasz Switaj and Anna B. Jakubowska and Piotr J. Wysocki and Andrzej Mackiewicz},
journal = {Cancer Immunology, Immunotherapy},
title = {Complete tumour regressions induced by vaccination with {IL}-12 gene-transduced tumour cells in combination with {IL}-15 in a melanoma model in mice},
year = {2004},
month = {apr},
number = {4},
pages = {363--372},
volume = {53},
doi = {10.1007/s00262-003-0449-9},
publisher = {Springer Science and Business Media {LLC}},
}
@Article{Rankin2003,
author = {Rankin, Erinn B. and Yu, Duonan and Jiang, Jiu and Shen, Hao and Pearce, Edward J. and Goldschmidt, Michael H. and Levy, David E. and Golovkina, Tatyana V. and Hunter, Christopher A. and Thomas-Tikhonenko, Andrei},
journal = {Cancer biology and therapy},
title = {An essential role of {Th1} responses and interferon gamma in infection-mediated suppression of neoplastic growth.},
year = {2003},
issn = {1538-4047},
pages = {687--693},
volume = {2},
abstract = {We had previously demonstrated that in mice acute toxoplasmosis leads to systemic inhibition of angiogenesis and, consequently, strong suppression of neoplastic growth. Here we investigated the role of Th1 cytokines, in particular interferon gamma (IFN-gamma), in this phenomenon. Besides toxoplasma, neoplastic growth was readily blocked during acute infection with other Th1 response-inducing pathogens such as Listeria monocytogenes and lymphocytic choriomeningitis virus (LCMV). In contrast, chronic infection with LCMV (when Th1 responses were strongly suppressed) and acute infection with Schistosoma mansoni (when Th2 responses predominated) afforded no anti-tumor protection. To corroborate the involvement of Th1 cytokines in infection-mediated suppression of neoplastic growth, we utilized mice deficient in interleukin-10 (IL10), a suppressor of Th1 responses. When challenged with B16 cells concomitantly with toxoplasma infection, both IL10-null and wild type mice exhibited resistance to neoplastic growth. However, tumors borne by IL10-null animals were even smaller than those borne by their wild type counterparts. This enhanced resistance correlated with dramatically elevated levels of circulating IFN-gamma, a principal Th1 cytokine. Furthermore, while interleukin-12 and tumor necrosis factor a were dispensable for tumor suppression, in animals deficient in IFN-gamma production or signaling, tumor growth and neovascularization were markedly enhanced. Interestingly, the enhancement was also apparent in uninfected animals suggesting that IFN-gamma and its anti-angiogenic effects underlie both infection-dependent and -independent tumor surveillance.},
chemicals = {Culture Media, Conditioned, Cytokines, Drug Combinations, Laminin, Proteoglycans, Vascular Endothelial Growth Factor A, matrigel, Interleukin-10, Interferon-gamma, Collagen},
author = {Nadia Luheshi and Gareth Davies and Edmund Poon and Kimberley Wiggins and Matthew McCourt and James Legg},
journal = {European Journal of Immunology},
title = {Th1 cytokines are more effective than Th2 cytokines at licensing anti-tumour functions in {CD}40-activated human macrophages in vitro},
year = {2013},
month = {oct},
number = {1},
pages = {162--172},
volume = {44},
doi = {10.1002/eji.201343351},
publisher = {Wiley},
}
@Article{Grotz2015,
author = {Travis E Grotz and James W Jakub and Aaron S Mansfield and Rachel Goldenstein and Elizabeth Ann L Enninga and Wendy K Nevala and Alexey A Leontovich and Svetomir N Markovic},
journal = {{OncoImmunology}},
title = {Evidence of Th2 polarization of the sentinel lymph node ({SLN}) in melanoma},
year = {2015},
month = {jun},
number = {8},
pages = {e1026504},
volume = {4},
doi = {10.1080/2162402x.2015.1026504},
publisher = {Informa {UK} Limited},
}
@Article{Ando2019,
author = {Makoto Ando and Minako Ito and Tanakorn Srirat and Taisuke Kondo and Akihiko Yoshimura},
journal = {Immunological Medicine},
title = {Memory T cell, exhaustion, and tumor immunity},
year = {2019},
month = {dec},
number = {1},
pages = {1--9},
volume = {43},
doi = {10.1080/25785826.2019.1698261},
publisher = {Informa {UK} Limited},
}
@Article{Wherry2015,
author = {E. John Wherry and Makoto Kurachi},
journal = {Nature Reviews Immunology},
title = {Molecular and cellular insights into T cell exhaustion},
year = {2015},
month = {jul},
number = {8},
pages = {486--499},
volume = {15},
doi = {10.1038/nri3862},
publisher = {Springer Science and Business Media {LLC}},
}
@Article{Zheng2017,
author = {Chunhong Zheng and Liangtao Zheng and Jae-Kwang Yoo and Huahu Guo and Yuanyuan Zhang and Xinyi Guo and Boxi Kang and Ruozhen Hu and Julie Y. Huang and Qiming Zhang and Zhouzerui Liu and Minghui Dong and Xueda Hu and Wenjun Ouyang and Jirun Peng and Zemin Zhang},
journal = {Cell},
title = {Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing},
author = {Cameron J. Turtle and Hillary M. Swanson and Nobuharu Fujii and Elihu H. Estey and Stanley R. Riddell},
journal = {Immunity},
title = {A Distinct Subset of Self-Renewing Human Memory {CD}8+ T Cells Survives Cytotoxic Chemotherapy},
year = {2009},
month = {nov},
number = {5},
pages = {834--844},
volume = {31},
doi = {10.1016/j.immuni.2009.09.015},
publisher = {Elsevier {BV}},
}
@Article{Donia2012,
author = {M. Donia and N. Junker and E. Ellebaek and M. H. Andersen and P. T. Straten and I. M. Svane},
journal = {Scandinavian Journal of Immunology},
title = {Characterization and Comparison of `Standard' and `Young' Tumour-Infiltrating Lymphocytes for Adoptive Cell Therapy at a Danish Translational Research Institution},
year = {2012},
month = {jan},
number = {2},
pages = {157--167},
volume = {75},
doi = {10.1111/j.1365-3083.2011.02640.x},
publisher = {Wiley},
}
@Article{Sheih2020,
author = {Alyssa Sheih and Valentin Voillet and Laïla-Aïcha Hanafi and Hannah A. DeBerg and Masanao Yajima and Reed Hawkins and Vivian Gersuk and Stanley R. Riddell and David G. Maloney and Martin E. Wohlfahrt and Dnyanada Pande and Mark R. Enstrom and Hans-Peter Kiem and Jennifer E. Adair and Raphaël Gottardo and Peter S. Linsley and Cameron J. Turtle},
journal = {Nature Communications},
title = {Clonal kinetics and single-cell transcriptional profiling of {CAR}-T cells in patients undergoing {CD}19 {CAR}-T immunotherapy},
year = {2020},
month = {jan},
number = {1},
volume = {11},
doi = {10.1038/s41467-019-13880-1},
publisher = {Springer Science and Business Media {LLC}},
}
@Article{Lee2013,
author = {Agnes Fermin Lee and Peter A. Sieling and Delphine J. Lee},
journal = {{OncoImmunology}},
title = {Immune correlates of melanoma survival in adoptive cell therapy},
year = {2013},
month = {feb},
number = {2},
pages = {e22889},
volume = {2},
doi = {10.4161/onci.22889},
publisher = {Informa {UK} Limited},
}
@Article{Wang2013,
author = {Weirong Wang and Chunfang Yan and Jiye Zhang and Rong Lin and Qinqin Lin and Lina Yang and Feng Ren and Jianfeng Zhang and Meixi Ji and Yanxiang Li},
journal = {Apoptosis},
title = {{SIRT}1 inhibits {TNF}-$\upalpha$-induced apoptosis of vascular adventitial fibroblasts partly through the deacetylation of {FoxO}1},
year = {2013},
month = {mar},
number = {6},
pages = {689--701},
volume = {18},
doi = {10.1007/s10495-013-0833-7},
publisher = {Springer Science and Business Media {LLC}},
booktitle = {Co-signal Molecules in T Cell Activation},
publisher = {Springer Singapore},
title = {Co-signal Molecules in T-Cell Activation},
year = {2019},
pages = {3--23},
doi = {10.1007/978-981-32-9717-3_1},
}
@Article{Luckheeram2012,
author = {Rishi Vishal Luckheeram and Rui Zhou and Asha Devi Verma and Bing Xia},
journal = {Clinical and Developmental Immunology},
title = {{CD}4+ T Cells: Differentiation and Functions},
year = {2012},
pages = {1--12},
volume = {2012},
doi = {10.1155/2012/925135},
publisher = {Hindawi Limited},
}
@Article{OConnor2012,
author = {Roddy S. O'Connor and Xueli Hao and Keyue Shen and Keenan Bashour and Tatiana Akimova and Wayne W. Hancock and Lance C. Kam and Michael C. Milone},
journal = {The Journal of Immunology},
title = {Substrate Rigidity Regulates Human T Cell Activation and Proliferation},
year = {2012},
month = {jun},
number = {3},
pages = {1330--1339},
volume = {189},
doi = {10.4049/jimmunol.1102757},
publisher = {The American Association of Immunologists},
author = {Daniel C. Kirouac and Peter W. Zandstra},
journal = {Cell Stem Cell},
title = {The Systematic Production of Cells for Cell Therapies},
year = {2008},
month = {oct},
number = {4},
pages = {369--381},
volume = {3},
doi = {10.1016/j.stem.2008.09.001},
publisher = {Elsevier {BV}},
}
@Article{Little2006,
author = {Melissa Little and Wayne Hall and Amy Orlandi},
journal = {{EMBO} reports},
title = {Delivering on the promise of human stem-cell research. What are the real barriers?},
year = {2006},
month = {nov},
number = {12},
pages = {1188--1192},
volume = {7},
doi = {10.1038/sj.embor.7400861},
publisher = {{EMBO}},
}
@Article{Pirnay2012,
author = {Jean-Paul Pirnay and Alain Vanderkelen and Nadine Ectors and Christian Delloye and Denis Dufrane and Etienne Baudoux and Michel Van Brussel and Michael P. Casaer and Daniel De Vos and Jean-Pierre Draye and Thomas Rose and Serge Jennes and Pierre Neirinckx and Geert Laire and Martin Zizi and Gilbert Verbeken},
journal = {Cell and Tissue Banking},
title = {Beware of the commercialization of human cells and tissues: situation in the European Union},
year = {2012},
month = {jun},
number = {3},
pages = {487--498},
volume = {13},
doi = {10.1007/s10561-012-9323-3},
publisher = {Springer Science and Business Media {LLC}},
}
@Article{Rousseau2013,
author = {Guillaume F. Rousseau and Marie-Catherine Giarratana and Luc Douay},
journal = {Biotechnology Journal},
title = {Large-scale production of red blood cells from stem cells: What are the technical challenges ahead?},
author = {Peng Qiu and Erin F Simonds and Sean C Bendall and Kenneth D Gibbs and Robert V Bruggner and Michael D Linderman and Karen Sachs and Garry P Nolan and Sylvia K Plevritis},
journal = {Nature Biotechnology},
title = {Extracting a cellular hierarchy from high-dimensional cytometry data with {SPADE}},
year = {2011},
month = {oct},
number = {10},
pages = {886--891},
volume = {29},
doi = {10.1038/nbt.1991},
publisher = {Springer Science and Business Media {LLC}},
}
@Article{Qiu2017,
author = {Peng Qiu},
journal = {Cytometry Part A},
title = {Toward deterministic and semiautomated {SPADE} analysis},
author = {Kamholz, A. E. and Schilling, E. A. and Yager, P.},
journal = {Biophysical journal},
title = {Optical measurement of transverse molecular diffusion in a microchannel.},
year = {2001},
issn = {0006-3495},
month = apr,
pages = {1967--1972},
volume = {80},
abstract = {Quantitative analysis of molecular diffusion is a necessity for the efficient design of most microfluidic devices as well as an important biophysical method in its own right. This study demonstrates the rapid measurement of diffusion coefficients of large and small molecules in a microfluidic device, the T-sensor, by means of conventional epifluorescence microscopy. Data were collected by monitoring the transverse flux of analyte from a sample stream into a second stream flowing alongside it. As indicated by the low Reynolds numbers of the system (< 1), flow is laminar, and molecular transport between streams occurs only by diffusion. Quantitative determinations were made by fitting data with predictions of a one-dimensional model. Analysis was made of the flow development and its effect on the distribution of diffusing analyte using a three-dimensional modeling software package. Diffusion coefficients were measured for four fluorescently labeled molecules: fluorescein-biotin, insulin, ovalbumin, and streptavidin. The resulting values differed from accepted results by an average of 2.4%. Microfluidic system parameters can be selected to achieve accurate diffusion coefficient measurements and to optimize other microfluidic devices that rely on precise transverse transport of molecules.},
author = {Doreen Niether and Mona Sarter and Bernd W. Koenig and Jörg Fitter and Andreas M. Stadler and Simone Wiegand},
journal = {Polymers},
title = {Thermophoresis: The Case of Streptavidin and Biotin},
year = {2020},
month = {feb},
number = {2},
pages = {376},
volume = {12},
doi = {10.3390/polym12020376},
publisher = {{MDPI} {AG}},
}
@Article{Kerwin2008,
author = {Kerwin, Bruce A.},
journal = {Journal of pharmaceutical sciences},
title = {Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.},
year = {2008},
issn = {1520-6017},
month = aug,
pages = {2924--2935},
volume = {97},
abstract = {Polysorbates 20 and 80 (Tween 20 and Tween 80) are used in the formulation of biotherapeutic products for both preventing surface adsorption and as stabilizers against protein aggregation. The polysorbates are amphipathic, nonionic surfactants composed of fatty acid esters of polyoxyethylene sorbitan being polyoxyethylene sorbitan monolaurate for polysorbate 20 and polyoxyethylene sorbitan monooleate for polysorbate 80. The polysorbates used in the formulation of biopharmaceuticals are mixtures of different fatty acid esters with the monolaurate fraction of polysorbate 20 making up only 40-60% of the mixture and the monooleate fraction of polysorbate 80 making up >58% of the mixture. The polysorbates undergo autooxidation, cleavage at the ethylene oxide subunits and hydrolysis of the fatty acid ester bond. Autooxidation results in hydroperoxide formation, side-chain cleavage and eventually formation of short chain acids such as formic acid all of which could influence the stability of a biopharmaceutical product. Oxidation of the fatty acid moiety while well described in the literature has not been specifically investigated for polysorbate. This review focuses on the chemical structure of the polysorbates, factors influencing micelle formation and factors and excipients influencing stability and degradation of the polyoxyethylene and fatty acid ester linkages.},
author = {Laura Lozza and Laura Rivino and Greta Guarda and David Jarrossay and Andrea Rinaldi and Francesco Bertoni and Federica Sallusto and Antonio Lanzavecchia and Jens Geginat},
journal = {European Journal of Immunology},
title = {The strength of T cell stimulation determines {IL}-7 responsiveness, secondary expansion, and lineage commitment of primed human {CD}4+{IL}-7Rhi T cells},
year = {2008},
month = {jan},
number = {1},
pages = {30--39},
volume = {38},
doi = {10.1002/eji.200737852},
publisher = {Wiley},
}
@Article{Lanzavecchia2005,
author = {Antonio Lanzavecchia and Federica Sallusto},
journal = {Current Opinion in Immunology},
title = {Understanding the generation and function of memory T cell subsets},
year = {2005},
month = {jun},
number = {3},
pages = {326--332},
volume = {17},
doi = {10.1016/j.coi.2005.04.010},
publisher = {Elsevier {BV}},
}
@Article{Corse2011,
author = {Emily Corse and Rachel A. Gottschalk and James P. Allison},
journal = {The Journal of Immunology},
title = {Strength of {TCR}{\textendash}Peptide/{MHC} Interactions and In Vivo T Cell Responses},
year = {2011},
month = {apr},
number = {9},
pages = {5039--5045},
volume = {186},
doi = {10.4049/jimmunol.1003650},
publisher = {The American Association of Immunologists},
author = {S. Del Guerra and C. Bracci and K. Nilsson and A. Belcourt and L. Kessler and R. Lupi and L. Marselli and P. De Vos and P. Marchetti},
journal = {Biotechnology and Bioengineering},
title = {Entrapment of dispersed pancreatic islet cells in {CultiSpher}-S macroporous gelatin microcarriers: Preparation, in vitro characterization, and microencapsulation},
year = {2001},
number = {6},
pages = {741--744},
volume = {75},
doi = {10.1002/bit.10053},
publisher = {Wiley},
}
@Article{Fernandes2007,
author = {A.M. Fernandes and T.G. Fernandes and M.M. Diogo and C. Lobato da Silva and D. Henrique and J.M.S. Cabral},
journal = {Journal of Biotechnology},
title = {Mouse embryonic stem cell expansion in a microcarrier-based stirred culture system},
year = {2007},
month = {oct},
number = {2},
pages = {227--236},
volume = {132},
doi = {10.1016/j.jbiotec.2007.05.031},
publisher = {Elsevier {BV}},
}
@Article{Storm_2010,
author = {Michael P. Storm and Craig B. Orchard and Heather K. Bone and Julian B. Chaudhuri and Melanie J. Welham},
journal = {Biotechnology and Bioengineering},
title = {Three-dimensional culture systems for the expansion of pluripotent embryonic stem cells},
year = {2010},
month = {jun},
number = {4},
pages = {683--695},
volume = {107},
doi = {10.1002/bit.22850},
publisher = {Wiley},
}
@Article{Eibes2010,
author = {Gemma Eibes and Francisco dos Santos and Pedro Z. Andrade and Joana S. Boura and Manuel M.A. Abecasis and Cl{\'{a}}udia Lobato da Silva and Joaquim M.S. Cabral},
journal = {Journal of Biotechnology},
title = {Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system},
author = {Steven A. Rosenberg and Beverly S. Packard and Paul M. Aebersold and Diane Solomon and Suzanne L. Topalian and Stephen T. Toy and Paul Simon and Michael T. Lotze and James C. Yang and Claudia A. Seipp and Colleen Simpson and Charles Carter and Steven Bock and Douglas Schwartzentruber and John P. Wei and Donald E. White},
journal = {New England Journal of Medicine},
title = {Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma},
author = {Frank Delaglio and Stephan Grzesiek and GeertenW. Vuister and Guang Zhu and John Pfeifer and Ad Bax},
journal = {Journal of Biomolecular {NMR}},
title = {{NMRPipe}: A multidimensional spectral processing system based on {UNIX} pipes},
year = {1995},
month = {nov},
number = {3},
volume = {6},
doi = {10.1007/bf00197809},
publisher = {Springer Science and Business Media {LLC}},
}
@Article{Dieterle2006,
author = {Frank Dieterle and Alfred Ross and Götz Schlotterbeck and Hans Senn},
journal = {Analytical Chemistry},
title = {Probabilistic Quotient Normalization as Robust Method to Account for Dilution of Complex Biological Mixtures. Application in1H {NMR} Metabonomics},
year = {2006},
month = {jul},
number = {13},
pages = {4281--4290},
volume = {78},
doi = {10.1021/ac051632c},
publisher = {American Chemical Society ({ACS})},
}
@Article{Dashti2017,
author = {Hesam Dashti and William M. Westler and Marco Tonelli and Jonathan R. Wedell and John L. Markley and Hamid R. Eghbalnia},
journal = {Analytical Chemistry},
title = {Spin System Modeling of Nuclear Magnetic Resonance Spectra for Applications in Metabolomics and Small Molecule Screening},
year = {2017},
month = {nov},
number = {22},
pages = {12201--12208},
volume = {89},
doi = {10.1021/acs.analchem.7b02884},
publisher = {American Chemical Society ({ACS})},
}
@InProceedings{Kordona,
author = {A.K. Kordon and Ching-Tai Lue},
booktitle = {Proceedings of the 2004 Congress on Evolutionary Computation ({IEEE} Cat. No.04TH8753)},
title = {Symbolic regression modeling of blown film process effects},
year = {2004},
publisher = {{IEEE}},
doi = {10.1109/cec.2004.1330907},
}
@Book{Koza1992,
author = {Koza, John},
publisher = {MIT Press},
title = {Genetic programming : on the programming of computers by means of natural selection},
